BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy2843
(113 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 76.3 bits (186), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 33/53 (62%), Positives = 42/53 (79%), Gaps = 1/53 (1%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
HF+HRD+AARNCL++C P R+ KIGDFG+ARDIYR YY+K G +LPV +
Sbjct: 187 HFIHRDIAARNCLLTCPGPG-RVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 238
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 76.3 bits (186), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 33/53 (62%), Positives = 42/53 (79%), Gaps = 1/53 (1%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
HF+HRD+AARNCL++C P R+ KIGDFG+ARDIYR YY+K G +LPV +
Sbjct: 177 HFIHRDIAARNCLLTCPGPG-RVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 228
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 76.3 bits (186), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 33/53 (62%), Positives = 42/53 (79%), Gaps = 1/53 (1%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
HF+HRD+AARNCL++C P R+ KIGDFG+ARDIYR YY+K G +LPV +
Sbjct: 161 HFIHRDIAARNCLLTCPGPG-RVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 212
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 76.3 bits (186), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 33/53 (62%), Positives = 42/53 (79%), Gaps = 1/53 (1%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
HF+HRD+AARNCL++C P R+ KIGDFG+ARDIYR YY+K G +LPV +
Sbjct: 167 HFIHRDIAARNCLLTCPGPG-RVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 218
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 76.3 bits (186), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 33/53 (62%), Positives = 42/53 (79%), Gaps = 1/53 (1%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
HF+HRD+AARNCL++C P R+ KIGDFG+ARDIYR YY+K G +LPV +
Sbjct: 175 HFIHRDIAARNCLLTCPGPG-RVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 76.3 bits (186), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 33/53 (62%), Positives = 42/53 (79%), Gaps = 1/53 (1%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
HF+HRD+AARNCL++C P R+ KIGDFG+ARDIYR YY+K G +LPV +
Sbjct: 175 HFIHRDIAARNCLLTCPGPG-RVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 76.3 bits (186), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 33/53 (62%), Positives = 42/53 (79%), Gaps = 1/53 (1%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
HF+HRD+AARNCL++C P R+ KIGDFG+ARDIYR YY+K G +LPV +
Sbjct: 161 HFIHRDIAARNCLLTCPGPG-RVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 212
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 76.3 bits (186), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 33/53 (62%), Positives = 42/53 (79%), Gaps = 1/53 (1%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
HF+HRD+AARNCL++C P R+ KIGDFG+ARDIYR YY+K G +LPV +
Sbjct: 160 HFIHRDIAARNCLLTCPGPG-RVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 76.3 bits (186), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 33/53 (62%), Positives = 42/53 (79%), Gaps = 1/53 (1%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
HF+HRD+AARNCL++C P R+ KIGDFG+ARDIYR YY+K G +LPV +
Sbjct: 160 HFIHRDIAARNCLLTCPGPG-RVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 76.3 bits (186), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 33/53 (62%), Positives = 42/53 (79%), Gaps = 1/53 (1%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
HF+HRD+AARNCL++C P R+ KIGDFG+ARDIYR YY+K G +LPV +
Sbjct: 175 HFIHRDIAARNCLLTCPGPG-RVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 76.3 bits (186), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 33/53 (62%), Positives = 42/53 (79%), Gaps = 1/53 (1%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
HF+HRD+AARNCL++C P R+ KIGDFG+ARDIYR YY+K G +LPV +
Sbjct: 152 HFIHRDIAARNCLLTCPGPG-RVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 203
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 75.9 bits (185), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 33/53 (62%), Positives = 42/53 (79%), Gaps = 1/53 (1%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
HF+HRD+AARNCL++C P R+ KIGDFG+ARDIYR YY+K G +LPV +
Sbjct: 201 HFIHRDIAARNCLLTCPGPG-RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 75.9 bits (185), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 33/53 (62%), Positives = 42/53 (79%), Gaps = 1/53 (1%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
HF+HRD+AARNCL++C P R+ KIGDFG+ARDIYR YY+K G +LPV +
Sbjct: 178 HFIHRDIAARNCLLTCPGPG-RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 229
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 74.7 bits (182), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 32/53 (60%), Positives = 42/53 (79%), Gaps = 1/53 (1%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
HF+HRD+AARNCL++C P R+ KIGDFG+A+DIYR YY+K G +LPV +
Sbjct: 161 HFIHRDIAARNCLLTCPGPG-RVAKIGDFGMAQDIYRASYYRKGGCAMLPVKW 212
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 71.2 bits (173), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 33/52 (63%), Positives = 40/52 (76%), Gaps = 4/52 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRDLAARNC+V+ + VKIGDFG+ RDIY DYY+K G+GLLPV +
Sbjct: 152 FVHRDLAARNCMVA----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 199
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 70.9 bits (172), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 33/52 (63%), Positives = 40/52 (76%), Gaps = 4/52 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRDLAARNC+V+ + VKIGDFG+ RDIY DYY+K G+GLLPV +
Sbjct: 152 FVHRDLAARNCMVA----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 199
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 70.9 bits (172), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 33/52 (63%), Positives = 40/52 (76%), Gaps = 4/52 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRDLAARNC+V+ + VKIGDFG+ RDIY DYY+K G+GLLPV +
Sbjct: 150 FVHRDLAARNCMVA----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 197
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 70.9 bits (172), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 33/52 (63%), Positives = 40/52 (76%), Gaps = 4/52 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRDLAARNC+V+ + VKIGDFG+ RDIY DYY+K G+GLLPV +
Sbjct: 146 FVHRDLAARNCMVA----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 193
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 70.9 bits (172), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 33/52 (63%), Positives = 40/52 (76%), Gaps = 4/52 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRDLAARNC+V+ + VKIGDFG+ RDIY DYY+K G+GLLPV +
Sbjct: 149 FVHRDLAARNCMVA----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 196
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 70.9 bits (172), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 33/52 (63%), Positives = 40/52 (76%), Gaps = 4/52 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRDLAARNC+V+ + VKIGDFG+ RDIY DYY+K G+GLLPV +
Sbjct: 159 FVHRDLAARNCMVA----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 70.9 bits (172), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 33/52 (63%), Positives = 40/52 (76%), Gaps = 4/52 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRDLAARNC+V+ + VKIGDFG+ RDIY DYY+K G+GLLPV +
Sbjct: 153 FVHRDLAARNCMVA----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 200
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 70.9 bits (172), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 33/52 (63%), Positives = 40/52 (76%), Gaps = 4/52 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRDLAARNC+V+ + VKIGDFG+ RDIY DYY+K G+GLLPV +
Sbjct: 159 FVHRDLAARNCMVA----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 70.5 bits (171), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 33/52 (63%), Positives = 40/52 (76%), Gaps = 4/52 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRDLAARNC+V+ + VKIGDFG+ RDIY DYY+K G+GLLPV +
Sbjct: 181 FVHRDLAARNCMVA----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 228
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 70.1 bits (170), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 33/52 (63%), Positives = 39/52 (75%), Gaps = 4/52 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRDLAARNC+V+ VKIGDFG+ RDIY DYY+K G+GLLPV +
Sbjct: 150 FVHRDLAARNCMVA----HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 197
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 70.1 bits (170), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 33/52 (63%), Positives = 39/52 (75%), Gaps = 4/52 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRDLAARNC+V+ VKIGDFG+ RDIY DYY+K G+GLLPV +
Sbjct: 151 FVHRDLAARNCMVA----HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 198
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 69.7 bits (169), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 33/52 (63%), Positives = 39/52 (75%), Gaps = 4/52 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRDLAARNC V+ + VKIGDFG+ RDIY DYY+K G+GLLPV +
Sbjct: 146 FVHRDLAARNCXVA----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 193
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 68.2 bits (165), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 32/52 (61%), Positives = 39/52 (75%), Gaps = 4/52 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHR+LAARNC+V+ VKIGDFG+ RDIY DYY+K G+GLLPV +
Sbjct: 151 FVHRNLAARNCMVA----HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 198
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 68.2 bits (165), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 32/52 (61%), Positives = 39/52 (75%), Gaps = 4/52 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHR+LAARNC+V+ VKIGDFG+ RDIY DYY+K G+GLLPV +
Sbjct: 152 FVHRNLAARNCMVA----HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 199
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 67.0 bits (162), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 30/54 (55%), Positives = 39/54 (72%), Gaps = 4/54 (7%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HFVHRDLA RNCLV + +VKIGDFG++RDIY DYY+ G +LP+ +
Sbjct: 177 LHFVHRDLATRNCLVG----QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 226
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 67.0 bits (162), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 32/52 (61%), Positives = 38/52 (73%), Gaps = 4/52 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRDLAARNC+V+ VKIGDFG+ RDIY YY+K G+GLLPV +
Sbjct: 151 FVHRDLAARNCMVA----HDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRW 198
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 67.0 bits (162), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 30/54 (55%), Positives = 39/54 (72%), Gaps = 4/54 (7%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HFVHRDLA RNCLV + +VKIGDFG++RDIY DYY+ G +LP+ +
Sbjct: 154 LHFVHRDLATRNCLVG----QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 203
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 67.0 bits (162), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 30/54 (55%), Positives = 39/54 (72%), Gaps = 4/54 (7%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HFVHRDLA RNCLV + +VKIGDFG++RDIY DYY+ G +LP+ +
Sbjct: 148 LHFVHRDLATRNCLVG----QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 197
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 65.9 bits (159), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 29/53 (54%), Positives = 38/53 (71%), Gaps = 4/53 (7%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
HFVHRDLA RNCLV + +VKIGDFG++RD+Y DYY+ G +LP+ +
Sbjct: 148 HFVHRDLATRNCLVG----ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 196
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 65.5 bits (158), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 29/53 (54%), Positives = 37/53 (69%), Gaps = 4/53 (7%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
HFVHRDLA RNCLV +VKIGDFG++RD+Y DYY+ G +LP+ +
Sbjct: 153 HFVHRDLATRNCLVGA----NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 201
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 62.0 bits (149), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 30/52 (57%), Positives = 37/52 (71%), Gaps = 4/52 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRDLAARNC+V+ + VKIGDFG+ RDI D +K G+GLLPV +
Sbjct: 144 FVHRDLAARNCMVA----EDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 191
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 62.0 bits (149), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 30/52 (57%), Positives = 37/52 (71%), Gaps = 4/52 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRDLAARNC+V+ + VKIGDFG+ RDI D +K G+GLLPV +
Sbjct: 153 FVHRDLAARNCMVA----EDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 200
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 61.2 bits (147), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 30/52 (57%), Positives = 36/52 (69%), Gaps = 4/52 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRDLAARNC+V+ VKIGDFG+ RDI D +K G+GLLPV +
Sbjct: 148 FVHRDLAARNCMVA----HDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 195
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 61.2 bits (147), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 30/52 (57%), Positives = 36/52 (69%), Gaps = 4/52 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRDLAARNC+V+ VKIGDFG+ RDI D +K G+GLLPV +
Sbjct: 151 FVHRDLAARNCMVA----HDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 198
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 61.2 bits (147), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 30/52 (57%), Positives = 36/52 (69%), Gaps = 4/52 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRDLAARNC+V+ VKIGDFG+ RDI D +K G+GLLPV +
Sbjct: 151 FVHRDLAARNCMVA----HDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 198
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 60.5 bits (145), Expect = 2e-10, Method: Composition-based stats.
Identities = 28/52 (53%), Positives = 36/52 (69%), Gaps = 4/52 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRDLA RNCLV + +VKI DFGL+R+IY DYYK +G +P+ +
Sbjct: 195 FVHRDLATRNCLVG----ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRW 242
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 59.3 bits (142), Expect = 6e-10, Method: Composition-based stats.
Identities = 29/51 (56%), Positives = 36/51 (70%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN LV+ + ++KI DFGLARDI+ DYYKK G LPV +
Sbjct: 213 IHRDLAARNVLVT----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKW 259
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 58.5 bits (140), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 29/51 (56%), Positives = 36/51 (70%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN LV+ + ++KI DFGLARDI+ DYYKK G LPV +
Sbjct: 165 IHRDLAARNVLVT----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKW 211
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 58.5 bits (140), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 29/51 (56%), Positives = 36/51 (70%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN LV+ + ++KI DFGLARDI+ DYYKK G LPV +
Sbjct: 172 IHRDLAARNVLVT----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKW 218
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 58.5 bits (140), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 29/51 (56%), Positives = 36/51 (70%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN LV+ + ++KI DFGLARDI+ DYYKK G LPV +
Sbjct: 172 IHRDLAARNVLVT----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKW 218
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 58.5 bits (140), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 29/51 (56%), Positives = 36/51 (70%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN LV+ + ++KI DFGLARDI+ DYYKK G LPV +
Sbjct: 161 IHRDLAARNVLVT----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKW 207
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 58.5 bits (140), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 29/51 (56%), Positives = 36/51 (70%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN LV+ + ++KI DFGLARDI+ DYYKK G LPV +
Sbjct: 172 IHRDLAARNVLVT----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKW 218
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 58.5 bits (140), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 29/51 (56%), Positives = 36/51 (70%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN LV+ + ++KI DFGLARDI+ DYYKK G LPV +
Sbjct: 164 IHRDLAARNVLVT----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKW 210
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 58.5 bits (140), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 29/51 (56%), Positives = 36/51 (70%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN LV+ + ++KI DFGLARDI+ DYYKK G LPV +
Sbjct: 157 IHRDLAARNVLVT----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKW 203
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 57.8 bits (138), Expect = 2e-09, Method: Composition-based stats.
Identities = 29/51 (56%), Positives = 35/51 (68%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN LV+ + ++KI DFGLARDI DYYKK G LPV +
Sbjct: 225 IHRDLAARNVLVT----ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKW 271
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 57.4 bits (137), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 31/62 (50%), Positives = 40/62 (64%), Gaps = 7/62 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVI 60
M VHRDLAARN LV+ + R +KI DFGL+RD+Y D Y K +G +PV + + I
Sbjct: 169 MKLVHRDLAARNILVA----EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKW---MAI 221
Query: 61 ES 62
ES
Sbjct: 222 ES 223
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 57.4 bits (137), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 29/51 (56%), Positives = 35/51 (68%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN LV+ + ++KI DFGLARDI DYYKK G LPV +
Sbjct: 179 IHRDLAARNVLVT----ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKW 225
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 57.4 bits (137), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 29/51 (56%), Positives = 35/51 (68%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN LV+ + ++KI DFGLARDI DYYKK G LPV +
Sbjct: 179 IHRDLAARNVLVT----ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKW 225
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 57.4 bits (137), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 29/51 (56%), Positives = 35/51 (68%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN LV+ + ++KI DFGLARDI DYYKK G LPV +
Sbjct: 179 IHRDLAARNVLVT----ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKW 225
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 57.0 bits (136), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 29/51 (56%), Positives = 35/51 (68%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN LV+ + ++KI DFGLARDI DYYKK G LPV +
Sbjct: 171 IHRDLAARNVLVT----ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKW 217
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 57.0 bits (136), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 29/51 (56%), Positives = 35/51 (68%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN LV+ + ++KI DFGLARDI DYYKK G LPV +
Sbjct: 179 IHRDLAARNVLVT----ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKW 225
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 57.0 bits (136), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 29/51 (56%), Positives = 35/51 (68%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN LV+ + ++KI DFGLARDI DYYKK G LPV +
Sbjct: 179 IHRDLAARNVLVT----ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKW 225
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 57.0 bits (136), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 29/51 (56%), Positives = 35/51 (68%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN LV+ + ++KI DFGLARDI DYYKK G LPV +
Sbjct: 168 IHRDLAARNVLVT----ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKW 214
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 56.2 bits (134), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 28/51 (54%), Positives = 35/51 (68%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN LV+ + +++I DFGLARDI DYYKK G LPV +
Sbjct: 179 IHRDLAARNVLVT----ENNVMRIADFGLARDINNIDYYKKTTNGRLPVKW 225
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 55.8 bits (133), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 28/51 (54%), Positives = 34/51 (66%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDL ARN LV+ + ++KI DFGLARDI DYYKK G LPV +
Sbjct: 166 IHRDLTARNVLVT----ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKW 212
>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With
N-(4-chlorophenyl)-2-
((pyridin-4-ylmethyl)amino)benzamide
Length = 360
Score = 55.5 bits (132), Expect = 7e-09, Method: Composition-based stats.
Identities = 27/51 (52%), Positives = 37/51 (72%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN L+S + +VKI DFGLARDIY+N Y ++G+ LP+ +
Sbjct: 221 IHRDLAARNILLS----ENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKW 267
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 55.5 bits (132), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 28/51 (54%), Positives = 34/51 (66%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN LV+ + ++KI DFGLARDI DYYK G LPV +
Sbjct: 179 IHRDLAARNVLVT----ENNVMKIADFGLARDINNIDYYKNTTNGRLPVKW 225
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 54.7 bits (130), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 30/62 (48%), Positives = 39/62 (62%), Gaps = 7/62 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVI 60
M VHRDLAARN LV+ + R +KI DFGL+RD+Y D K +G +PV + + I
Sbjct: 169 MKLVHRDLAARNILVA----EGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKW---MAI 221
Query: 61 ES 62
ES
Sbjct: 222 ES 223
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 54.3 bits (129), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 30/62 (48%), Positives = 39/62 (62%), Gaps = 7/62 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVI 60
M VHRDLAARN LV+ + R +KI DFGL+RD+Y D K +G +PV + + I
Sbjct: 169 MSLVHRDLAARNILVA----EGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKW---MAI 221
Query: 61 ES 62
ES
Sbjct: 222 ES 223
>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With
Compound A
Length = 356
Score = 54.3 bits (129), Expect = 2e-08, Method: Composition-based stats.
Identities = 26/51 (50%), Positives = 37/51 (72%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN L+S + +VKI DFGLARDIY++ Y ++G+ LP+ +
Sbjct: 213 IHRDLAARNILLS----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 259
>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Back Pocket Binder
Length = 368
Score = 54.3 bits (129), Expect = 2e-08, Method: Composition-based stats.
Identities = 26/51 (50%), Positives = 37/51 (72%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN L+S + +VKI DFGLARDIY++ Y ++G+ LP+ +
Sbjct: 222 IHRDLAARNILLS----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 268
>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A
Novel Pyrrolopyrimidine Inhibitor
Length = 359
Score = 54.3 bits (129), Expect = 2e-08, Method: Composition-based stats.
Identities = 26/51 (50%), Positives = 37/51 (72%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN L+S + +VKI DFGLARDIY++ Y ++G+ LP+ +
Sbjct: 215 IHRDLAARNILLS----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261
>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
pdb|1Y6B|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
Length = 366
Score = 54.3 bits (129), Expect = 2e-08, Method: Composition-based stats.
Identities = 26/51 (50%), Positives = 37/51 (72%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN L+S + +VKI DFGLARDIY++ Y ++G+ LP+ +
Sbjct: 220 IHRDLAARNILLS----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 266
>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Axitinib (Ag-013736)
(N-Methyl-2-(
3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-
Benzamide)
pdb|4AGD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sunitinib (Su11248) (N-2-
Diethylaminoethyl)-5-((Z)-(5-Fluoro-2-Oxo-1h-Indol-3-
Ylidene)methyl)-2,4-Dimethyl-1h-Pyrrole-3-Carboxamide)
pdb|4ASD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sorafenib (Bay 43-9006)
pdb|4ASE|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Tivozanib (Av-951)
Length = 353
Score = 54.3 bits (129), Expect = 2e-08, Method: Composition-based stats.
Identities = 26/51 (50%), Positives = 37/51 (72%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN L+S + +VKI DFGLARDIY++ Y ++G+ LP+ +
Sbjct: 207 IHRDLAARNILLS----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 253
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 53.9 bits (128), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 29/63 (46%), Positives = 40/63 (63%), Gaps = 6/63 (9%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGE--GLLPVSFAITVVI 60
FVHRDLAARNC+ LD K+ VK+ DFGLARD+Y +YY + LPV + +
Sbjct: 173 FVHRDLAARNCM---LDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 228
Query: 61 ESK 63
+++
Sbjct: 229 QTQ 231
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 53.9 bits (128), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 29/63 (46%), Positives = 40/63 (63%), Gaps = 6/63 (9%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGE--GLLPVSFAITVVI 60
FVHRDLAARNC+ LD K+ VK+ DFGLARD+Y +YY + LPV + +
Sbjct: 154 FVHRDLAARNCM---LDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 61 ESK 63
+++
Sbjct: 210 QTQ 212
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 53.9 bits (128), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 29/63 (46%), Positives = 40/63 (63%), Gaps = 6/63 (9%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGE--GLLPVSFAITVVI 60
FVHRDLAARNC+ LD K+ VK+ DFGLARD+Y +YY + LPV + +
Sbjct: 172 FVHRDLAARNCM---LDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 227
Query: 61 ESK 63
+++
Sbjct: 228 QTQ 230
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 53.9 bits (128), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 29/63 (46%), Positives = 40/63 (63%), Gaps = 6/63 (9%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGE--GLLPVSFAITVVI 60
FVHRDLAARNC+ LD K+ VK+ DFGLARD+Y +YY + LPV + +
Sbjct: 153 FVHRDLAARNCM---LDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 208
Query: 61 ESK 63
+++
Sbjct: 209 QTQ 211
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 53.9 bits (128), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 29/63 (46%), Positives = 40/63 (63%), Gaps = 6/63 (9%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGE--GLLPVSFAITVVI 60
FVHRDLAARNC+ LD K+ VK+ DFGLARD+Y +YY + LPV + +
Sbjct: 154 FVHRDLAARNCM---LDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 61 ESK 63
+++
Sbjct: 210 QTQ 212
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 53.9 bits (128), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 29/63 (46%), Positives = 40/63 (63%), Gaps = 6/63 (9%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGE--GLLPVSFAITVVI 60
FVHRDLAARNC+ LD K+ VK+ DFGLARD+Y +YY + LPV + +
Sbjct: 151 FVHRDLAARNCM---LDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 206
Query: 61 ESK 63
+++
Sbjct: 207 QTQ 209
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 53.9 bits (128), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 29/63 (46%), Positives = 40/63 (63%), Gaps = 6/63 (9%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGE--GLLPVSFAITVVI 60
FVHRDLAARNC+ LD K+ VK+ DFGLARD+Y +YY + LPV + +
Sbjct: 152 FVHRDLAARNCM---LDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 207
Query: 61 ESK 63
+++
Sbjct: 208 QTQ 210
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 53.9 bits (128), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 29/63 (46%), Positives = 40/63 (63%), Gaps = 6/63 (9%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGE--GLLPVSFAITVVI 60
FVHRDLAARNC+ LD K+ VK+ DFGLARD+Y +YY + LPV + +
Sbjct: 149 FVHRDLAARNCM---LDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 61 ESK 63
+++
Sbjct: 205 QTQ 207
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 53.9 bits (128), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 29/63 (46%), Positives = 40/63 (63%), Gaps = 6/63 (9%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGE--GLLPVSFAITVVI 60
FVHRDLAARNC+ LD K+ VK+ DFGLARD+Y +YY + LPV + +
Sbjct: 146 FVHRDLAARNCM---LDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 201
Query: 61 ESK 63
+++
Sbjct: 202 QTQ 204
>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 53.1 bits (126), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 26/51 (50%), Positives = 37/51 (72%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN L+S + +VKI DFGLARDIY++ Y ++G+ LP+ +
Sbjct: 166 IHRDLAARNILLS----EKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKW 212
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 52.8 bits (125), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 27/51 (52%), Positives = 34/51 (66%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN LV+ + ++KI DFGLARDI+ D KK G LPV +
Sbjct: 172 IHRDLAARNVLVT----EDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKW 218
>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2
With A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 318
Score = 52.4 bits (124), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 26/51 (50%), Positives = 37/51 (72%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN L+S + +VKI DFGLARDIY++ Y ++G+ LP+ +
Sbjct: 172 IHRDLAARNILLS----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 218
>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy)
Quinolin-4-Yloxy)benzofuran-3-Carboxamide)
pdb|4AG8|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Axitinib (Ag-013736)
(N-Methyl-2-(3-((E)-2-Pyridin-2-
Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-Benzamide)
Length = 316
Score = 52.4 bits (124), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 26/51 (50%), Positives = 37/51 (72%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN L+S + +VKI DFGLARDIY++ Y ++G+ LP+ +
Sbjct: 170 IHRDLAARNILLS----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 216
>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridyl-Pyrimidine Benzimidazole Inhibitor
Length = 314
Score = 52.4 bits (124), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 26/51 (50%), Positives = 37/51 (72%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN L+S + +VKI DFGLARDIY++ Y ++G+ LP+ +
Sbjct: 161 IHRDLAARNILLS----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 207
>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 52.4 bits (124), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 26/51 (50%), Positives = 37/51 (72%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN L+S + +VKI DFGLARDIY++ Y ++G+ LP+ +
Sbjct: 166 IHRDLAARNILLS----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 212
>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyrazolone Inhibitor
Length = 314
Score = 52.0 bits (123), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 26/51 (50%), Positives = 37/51 (72%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN L+S + +VKI DFGLARDIY++ Y ++G+ LP+ +
Sbjct: 161 IHRDLAARNILLS----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 207
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 51.6 bits (122), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 28/62 (45%), Positives = 38/62 (61%), Gaps = 6/62 (9%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYY--KKEGEGLLPVSFAITVVI 60
FVHRDLAARNC+ LD + VK+ DFGLARDI +YY ++ LPV + +
Sbjct: 145 FVHRDLAARNCM---LDESF-TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 61 ES 62
++
Sbjct: 201 QT 202
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 51.6 bits (122), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 27/51 (52%), Positives = 33/51 (64%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN LV+ + ++KI DFGLARDI D KK G LPV +
Sbjct: 179 IHRDLAARNVLVT----ENNVMKIADFGLARDINNIDXXKKTTNGRLPVKW 225
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 51.2 bits (121), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 27/51 (52%), Positives = 33/51 (64%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN LV+ + ++KI DFGLARDI D KK G LPV +
Sbjct: 179 IHRDLAARNVLVT----ENNVMKIADFGLARDINNIDXXKKTTNGRLPVKW 225
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 51.2 bits (121), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 24/53 (45%), Positives = 35/53 (66%), Gaps = 4/53 (7%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+F+HRDLAARNC+++ + V + DFGL+R IY DYY++ LPV +
Sbjct: 157 NFIHRDLAARNCMLA----EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains.
pdb|2J0K|B Chain B, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 50.8 bits (120), Expect = 2e-07, Method: Composition-based stats.
Identities = 27/52 (51%), Positives = 35/52 (67%), Gaps = 5/52 (9%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRD+AARN LVS D VK+GDFGL+R + + YYK +G LP+ +
Sbjct: 512 FVHRDIAARNVLVSATD----CVKLGDFGLSRYMEDSTYYKAS-KGKLPIKW 558
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 50.4 bits (119), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 29/64 (45%), Positives = 41/64 (64%), Gaps = 8/64 (12%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDY---YKKEGEGLLPVSFAITVV 59
FVHRDLAARNC+ LD K+ VK+ DFGLARD+Y ++ + K G LPV +
Sbjct: 152 FVHRDLAARNCM---LDEKF-TVKVADFGLARDMYDKEFDSVHNKTG-AKLPVKWMALES 206
Query: 60 IESK 63
++++
Sbjct: 207 LQTQ 210
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 50.4 bits (119), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 29/64 (45%), Positives = 41/64 (64%), Gaps = 8/64 (12%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDY---YKKEGEGLLPVSFAITVV 59
FVHRDLAARNC+ LD K+ VK+ DFGLARD+Y ++ + K G LPV +
Sbjct: 159 FVHRDLAARNCM---LDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAK-LPVKWMALES 213
Query: 60 IESK 63
++++
Sbjct: 214 LQTQ 217
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 50.4 bits (119), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 29/64 (45%), Positives = 41/64 (64%), Gaps = 8/64 (12%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDY---YKKEGEGLLPVSFAITVV 59
FVHRDLAARNC+ LD K+ VK+ DFGLARD+Y ++ + K G LPV +
Sbjct: 213 FVHRDLAARNCM---LDEKF-TVKVADFGLARDMYDKEFDSVHNKTG-AKLPVKWMALES 267
Query: 60 IESK 63
++++
Sbjct: 268 LQTQ 271
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 50.4 bits (119), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 29/64 (45%), Positives = 41/64 (64%), Gaps = 8/64 (12%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDY---YKKEGEGLLPVSFAITVV 59
FVHRDLAARNC+ LD K+ VK+ DFGLARD+Y ++ + K G LPV +
Sbjct: 154 FVHRDLAARNCM---LDEKF-TVKVADFGLARDMYDKEFDSVHNKTG-AKLPVKWMALES 208
Query: 60 IESK 63
++++
Sbjct: 209 LQTQ 212
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 50.4 bits (119), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 29/64 (45%), Positives = 41/64 (64%), Gaps = 8/64 (12%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDY---YKKEGEGLLPVSFAITVV 59
FVHRDLAARNC+ LD K+ VK+ DFGLARD+Y ++ + K G LPV +
Sbjct: 155 FVHRDLAARNCM---LDEKF-TVKVADFGLARDMYDKEFDSVHNKTG-AKLPVKWMALES 209
Query: 60 IESK 63
++++
Sbjct: 210 LQTQ 213
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 50.4 bits (119), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 29/64 (45%), Positives = 41/64 (64%), Gaps = 8/64 (12%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDY---YKKEGEGLLPVSFAITVV 59
FVHRDLAARNC+ LD K+ VK+ DFGLARD+Y ++ + K G LPV +
Sbjct: 154 FVHRDLAARNCM---LDEKF-TVKVADFGLARDMYDKEFDSVHNKTG-AKLPVKWMALES 208
Query: 60 IESK 63
++++
Sbjct: 209 LQTQ 212
>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
pdb|2JKO|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 50.4 bits (119), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 27/52 (51%), Positives = 35/52 (67%), Gaps = 5/52 (9%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRD+AARN LVS D VK+GDFGL+R + + YYK +G LP+ +
Sbjct: 132 FVHRDIAARNVLVSATD----CVKLGDFGLSRYMEDSTYYKA-SKGKLPIKW 178
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 50.4 bits (119), Expect = 2e-07, Method: Composition-based stats.
Identities = 27/51 (52%), Positives = 32/51 (62%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV+ ++VKI DFGLARDI + Y G LPV +
Sbjct: 194 VHRDLAARNVLVT----HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKW 240
>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 49.7 bits (117), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 27/52 (51%), Positives = 35/52 (67%), Gaps = 5/52 (9%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRD+AARN LVS D VK+GDFGL+R + + YYK +G LP+ +
Sbjct: 512 FVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKA-SKGKLPIKW 558
>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
pdb|4EBV|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
Length = 304
Score = 49.3 bits (116), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 27/52 (51%), Positives = 35/52 (67%), Gaps = 5/52 (9%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRD+AARN LVS D VK+GDFGL+R + + YYK +G LP+ +
Sbjct: 160 FVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKA-SKGKLPIKW 206
>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr)
Kinase Domain
Length = 316
Score = 49.3 bits (116), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 25/51 (49%), Positives = 36/51 (70%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN L+S + +VKI DFGLARDIY++ ++G+ LP+ +
Sbjct: 170 IHRDLAARNILLS----EKNVVKICDFGLARDIYKDPDXVRKGDARLPLKW 216
>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2ETM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2IJM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
pdb|2IJM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
Length = 281
Score = 49.3 bits (116), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 27/52 (51%), Positives = 35/52 (67%), Gaps = 5/52 (9%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRD+AARN LVS D VK+GDFGL+R + + YYK +G LP+ +
Sbjct: 134 FVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKA-SKGKLPIKW 180
>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak)
pdb|4I4F|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With An Allosteric Binding Pyrazolobenzothiazine
Compound
Length = 281
Score = 49.3 bits (116), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 27/52 (51%), Positives = 35/52 (67%), Gaps = 5/52 (9%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRD+AARN LVS D VK+GDFGL+R + + YYK +G LP+ +
Sbjct: 137 FVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKA-SKGKLPIKW 183
>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
pdb|3PXK|B Chain B, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
Length = 282
Score = 49.3 bits (116), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 27/52 (51%), Positives = 35/52 (67%), Gaps = 5/52 (9%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRD+AARN LVS D VK+GDFGL+R + + YYK +G LP+ +
Sbjct: 135 FVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKA-SKGKLPIKW 181
>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A
Methanesulfonamide Diaminopyrimidine Inhibitor
Length = 276
Score = 49.3 bits (116), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 27/52 (51%), Positives = 35/52 (67%), Gaps = 5/52 (9%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRD+AARN LVS D VK+GDFGL+R + + YYK +G LP+ +
Sbjct: 129 FVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKA-SKGKLPIKW 175
>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 49.3 bits (116), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 27/52 (51%), Positives = 35/52 (67%), Gaps = 5/52 (9%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRD+AARN LVS D VK+GDFGL+R + + YYK +G LP+ +
Sbjct: 132 FVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKA-SKGKLPIKW 178
>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And
Kinase Domains Of Focal Adhesion Kinase.
pdb|2JKQ|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 49.3 bits (116), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 27/52 (51%), Positives = 35/52 (67%), Gaps = 5/52 (9%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRD+AARN LVS D VK+GDFGL+R + + YYK +G LP+ +
Sbjct: 132 FVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKA-SKGKLPIKW 178
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 48.9 bits (115), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 29/64 (45%), Positives = 40/64 (62%), Gaps = 8/64 (12%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDY---YKKEGEGLLPVSFAITVV 59
FVHRDLAARNC+ LD K+ VK+ DFGLARD+Y + + K G LPV +
Sbjct: 153 FVHRDLAARNCM---LDEKF-TVKVADFGLARDMYDKEXXSVHNKTG-AKLPVKWMALES 207
Query: 60 IESK 63
++++
Sbjct: 208 LQTQ 211
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 48.9 bits (115), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 40/89 (44%), Gaps = 18/89 (20%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVIE 61
H VH+DLA RN LV VKI D GL R++Y DYYK G LLP+ +
Sbjct: 165 HVVHKDLATRNVLVY----DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRW------- 213
Query: 62 SKNRSVPFRPELCVYGPLADIDSIKKVGI 90
PE +YG + I G+
Sbjct: 214 -------MAPEAIMYGKFSIDSDIWSYGV 235
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 48.5 bits (114), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 32/89 (35%), Positives = 40/89 (44%), Gaps = 18/89 (20%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVIE 61
H VH+DLA RN LV VKI D GL R++Y DYYK G LLP+ +
Sbjct: 148 HVVHKDLATRNVLVY----DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRW------- 196
Query: 62 SKNRSVPFRPELCVYGPLADIDSIKKVGI 90
PE +YG + I G+
Sbjct: 197 -------MAPEAIMYGKFSIDSDIWSYGV 218
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 48.1 bits (113), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 26/51 (50%), Positives = 32/51 (62%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN L++ RI KI DFGLARDI + Y +G LPV +
Sbjct: 183 IHRDLAARNILLT----HGRITKICDFGLARDIKNDSNYVVKGNARLPVKW 229
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 48.1 bits (113), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 24/51 (47%), Positives = 32/51 (62%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRD+AARN L++ + KIGDFGLARDI + Y +G LPV +
Sbjct: 180 IHRDVAARNVLLT----NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 226
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 47.8 bits (112), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 26/51 (50%), Positives = 32/51 (62%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN L++ RI KI DFGLARDI + Y +G LPV +
Sbjct: 185 IHRDLAARNILLT----HGRITKICDFGLARDIKNDSNYVVKGNARLPVKW 231
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 47.8 bits (112), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 24/51 (47%), Positives = 32/51 (62%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRD+AARN L++ + KIGDFGLARDI + Y +G LPV +
Sbjct: 186 IHRDVAARNVLLT----NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 232
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 47.8 bits (112), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 26/51 (50%), Positives = 32/51 (62%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN L++ RI KI DFGLARDI + Y +G LPV +
Sbjct: 167 IHRDLAARNILLT----HGRITKICDFGLARDIKNDSNYVVKGNARLPVKW 213
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 47.8 bits (112), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 24/51 (47%), Positives = 32/51 (62%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRD+AARN L++ + KIGDFGLARDI + Y +G LPV +
Sbjct: 186 IHRDVAARNVLLT----NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 232
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 47.8 bits (112), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 26/51 (50%), Positives = 32/51 (62%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN L++ RI KI DFGLARDI + Y +G LPV +
Sbjct: 190 IHRDLAARNILLT----HGRITKICDFGLARDIKNDSNYVVKGNARLPVKW 236
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 47.8 bits (112), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 24/51 (47%), Positives = 32/51 (62%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRD+AARN L++ + KIGDFGLARDI + Y +G LPV +
Sbjct: 174 IHRDVAARNVLLT----NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 220
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 47.8 bits (112), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 28/64 (43%), Positives = 40/64 (62%), Gaps = 8/64 (12%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDY---YKKEGEGLLPVSFAITVV 59
FVHRDLAARNC+ LD K+ VK+ DFGLARD+ ++ + K G LPV +
Sbjct: 155 FVHRDLAARNCM---LDEKF-TVKVADFGLARDMLDKEFDSVHNKTG-AKLPVKWMALES 209
Query: 60 IESK 63
++++
Sbjct: 210 LQTQ 213
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 47.8 bits (112), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 8/77 (10%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVIE 61
+F+HRDLAARNC++ V + DFGL++ IY DYY++ +PV + + IE
Sbjct: 167 NFLHRDLAARNCMLR----DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW---IAIE 219
Query: 62 S-KNRSVPFRPELCVYG 77
S +R + ++ +G
Sbjct: 220 SLADRVYTSKSDVWAFG 236
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 47.8 bits (112), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 24/51 (47%), Positives = 32/51 (62%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRD+AARN L++ + KIGDFGLARDI + Y +G LPV +
Sbjct: 188 IHRDVAARNVLLT----NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 234
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 47.4 bits (111), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 24/51 (47%), Positives = 32/51 (62%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRD+AARN L++ + KIGDFGLARDI + Y +G LPV +
Sbjct: 182 IHRDVAARNVLLT----NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 228
>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea
Inhibitor
Length = 316
Score = 46.6 bits (109), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 24/51 (47%), Positives = 35/51 (68%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN L+S + +VKI DFGLARDI ++ ++G+ LP+ +
Sbjct: 170 IHRDLAARNILLS----EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKW 216
>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel
4-amino-furo[2,3-d]pyrimidine
Length = 316
Score = 46.6 bits (109), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 24/51 (47%), Positives = 35/51 (68%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN L+S + +VKI DFGLARDI ++ ++G+ LP+ +
Sbjct: 170 IHRDLAARNILLS----EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKW 216
>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120
Length = 316
Score = 46.6 bits (109), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 24/51 (47%), Positives = 35/51 (68%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN L+S + +VKI DFGLARDI ++ ++G+ LP+ +
Sbjct: 170 IHRDLAARNILLS----EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKW 216
>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridinyl-Triazine Inhibitor
pdb|2QU5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzimidazole Inhibitor
pdb|2QU6|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|2QU6|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|3B8Q|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8Q|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|2RL5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A 2,3-Dihydro-1,4-Benzoxazine Inhibitor
pdb|3BE2|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzamide Inhibitor
pdb|3CP9|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CP9|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPB|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPB|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPC|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPC|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3DTW|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
pdb|3DTW|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
Length = 314
Score = 46.2 bits (108), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 24/51 (47%), Positives = 35/51 (68%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN L+S + +VKI DFGLARDI ++ ++G+ LP+ +
Sbjct: 161 IHRDLAARNILLS----EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKW 207
>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|2P2I|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|3EFL|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
pdb|3EFL|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
Length = 314
Score = 46.2 bits (108), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 24/51 (47%), Positives = 35/51 (68%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN L+S + +VKI DFGLARDI ++ ++G+ LP+ +
Sbjct: 161 IHRDLAARNILLS----EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKW 207
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 46.2 bits (108), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 30/77 (38%), Positives = 41/77 (53%), Gaps = 9/77 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND--YYKKEGEGLLPVSFAITVVI 60
F+HRDLAARN L++ D +VKIGDFGL R + +ND Y +E V FA
Sbjct: 136 FIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDHYVMQEHR---KVPFAWCAPE 188
Query: 61 ESKNRSVPFRPELCVYG 77
K R+ + ++G
Sbjct: 189 SLKTRTFSHASDTWMFG 205
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 46.2 bits (108), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 30/77 (38%), Positives = 41/77 (53%), Gaps = 9/77 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND--YYKKEGEGLLPVSFAITVVI 60
F+HRDLAARN L++ D +VKIGDFGL R + +ND Y +E V FA
Sbjct: 132 FIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDHYVMQEHR---KVPFAWCAPE 184
Query: 61 ESKNRSVPFRPELCVYG 77
K R+ + ++G
Sbjct: 185 SLKTRTFSHASDTWMFG 201
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 46.2 bits (108), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 30/77 (38%), Positives = 41/77 (53%), Gaps = 9/77 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND--YYKKEGEGLLPVSFAITVVI 60
F+HRDLAARN L++ D +VKIGDFGL R + +ND Y +E V FA
Sbjct: 142 FIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDHYVMQEHR---KVPFAWCAPE 194
Query: 61 ESKNRSVPFRPELCVYG 77
K R+ + ++G
Sbjct: 195 SLKTRTFSHASDTWMFG 211
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 45.8 bits (107), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 30/77 (38%), Positives = 41/77 (53%), Gaps = 9/77 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND--YYKKEGEGLLPVSFAITVVI 60
F+HRDLAARN L++ D +VKIGDFGL R + +ND Y +E V FA
Sbjct: 132 FIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDHYVMQEHR---KVPFAWCAPE 184
Query: 61 ESKNRSVPFRPELCVYG 77
K R+ + ++G
Sbjct: 185 SLKTRTFSHASDTWMFG 201
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 45.8 bits (107), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 29/75 (38%), Positives = 40/75 (53%), Gaps = 5/75 (6%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVIES 62
F+HRDLAARN L++ D +VKIGDFGL R + +ND + E V FA
Sbjct: 132 FIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDHXVMQEH-RKVPFAWCAPESL 186
Query: 63 KNRSVPFRPELCVYG 77
K R+ + ++G
Sbjct: 187 KTRTFSHASDTWMFG 201
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 45.8 bits (107), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 29/75 (38%), Positives = 40/75 (53%), Gaps = 5/75 (6%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVIES 62
F+HRDLAARN L++ D +VKIGDFGL R + +ND + E V FA
Sbjct: 142 FIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDHXVMQEH-RKVPFAWCAPESL 196
Query: 63 KNRSVPFRPELCVYG 77
K R+ + ++G
Sbjct: 197 KTRTFSHASDTWMFG 211
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 45.8 bits (107), Expect = 6e-06, Method: Composition-based stats.
Identities = 22/38 (57%), Positives = 28/38 (73%), Gaps = 4/38 (10%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND 40
F+HRDLAARN L++ D +VKIGDFGL R + +ND
Sbjct: 136 FIHRDLAARNLLLATRD----LVKIGDFGLMRALPQND 169
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 45.1 bits (105), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 25/51 (49%), Positives = 31/51 (60%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN L++ RI KI DFGLAR I + Y +G LPV +
Sbjct: 190 IHRDLAARNILLT----HGRITKICDFGLARHIKNDSNYVVKGNARLPVKW 236
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 45.1 bits (105), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 22/54 (40%), Positives = 31/54 (57%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
+F+HRDLAARNCLV + +VK+ DFGL+R + D Y P+ +
Sbjct: 150 NFIHRDLAARNCLVG----ENHVVKVADFGLSR-LMTGDTYTAHAGAKFPIKWT 198
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 45.1 bits (105), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 33/79 (41%), Positives = 43/79 (54%), Gaps = 11/79 (13%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVIE 61
F+HRDLAARN LV + + KI DFGL+R + Y K+ G LPV + + IE
Sbjct: 162 QFIHRDLAARNILVG----ENYVAKIADFGLSRG---QEVYVKKTMGRLPVRW---MAIE 211
Query: 62 SKNRSV-PFRPELCVYGPL 79
S N SV ++ YG L
Sbjct: 212 SLNYSVYTTNSDVWSYGVL 230
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 45.1 bits (105), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 33/79 (41%), Positives = 43/79 (54%), Gaps = 11/79 (13%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVIE 61
F+HRDLAARN LV + + KI DFGL+R + Y K+ G LPV + + IE
Sbjct: 152 QFIHRDLAARNILVG----ENYVAKIADFGLSRG---QEVYVKKTMGRLPVRW---MAIE 201
Query: 62 SKNRSV-PFRPELCVYGPL 79
S N SV ++ YG L
Sbjct: 202 SLNYSVYTTNSDVWSYGVL 220
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 44.7 bits (104), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 23/54 (42%), Positives = 33/54 (61%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
F+HRDLAARNCLV+ +VK+ DFGL+R + ++Y G PV ++
Sbjct: 125 QFLHRDLAARNCLVN----DQGVVKVSDFGLSRYVLDDEYTSSRGSK-FPVRWS 173
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 44.7 bits (104), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 22/54 (40%), Positives = 31/54 (57%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
+F+HRDLAARNCLV + +VK+ DFGL+R + D Y P+ +
Sbjct: 136 NFIHRDLAARNCLVG----ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWT 184
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 44.7 bits (104), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 22/54 (40%), Positives = 31/54 (57%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
+F+HRDLAARNCLV + +VK+ DFGL+R + D Y P+ +
Sbjct: 136 NFIHRDLAARNCLVG----ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWT 184
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 44.7 bits (104), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 22/54 (40%), Positives = 31/54 (57%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
+F+HRDLAARNCLV + +VK+ DFGL+R + D Y P+ +
Sbjct: 136 NFIHRDLAARNCLVG----ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWT 184
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 44.7 bits (104), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 22/54 (40%), Positives = 31/54 (57%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
+F+HRDLAARNCLV + +VK+ DFGL+R + D Y P+ +
Sbjct: 136 NFIHRDLAARNCLVG----ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWT 184
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 44.7 bits (104), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 22/54 (40%), Positives = 31/54 (57%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
+F+HRDLAARNCLV + +VK+ DFGL+R + D Y P+ +
Sbjct: 135 NFIHRDLAARNCLVG----ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWT 183
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 44.7 bits (104), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 22/54 (40%), Positives = 31/54 (57%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
+F+HRDLAARNCLV + +VK+ DFGL+R + D Y P+ +
Sbjct: 131 NFIHRDLAARNCLVG----ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWT 179
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 44.7 bits (104), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 22/54 (40%), Positives = 31/54 (57%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
+F+HRDLAARNCLV + +VK+ DFGL+R + D Y P+ +
Sbjct: 131 NFIHRDLAARNCLVG----ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWT 179
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 44.7 bits (104), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 22/54 (40%), Positives = 31/54 (57%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
+F+HRDLAARNCLV + +VK+ DFGL+R + D Y P+ +
Sbjct: 131 NFIHRDLAARNCLVG----ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWT 179
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 44.7 bits (104), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 22/54 (40%), Positives = 31/54 (57%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
+F+HRDLAARNCLV + +VK+ DFGL+R + D Y P+ +
Sbjct: 144 NFIHRDLAARNCLVG----ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWT 192
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 44.7 bits (104), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 22/54 (40%), Positives = 31/54 (57%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
+F+HRDLAARNCLV + +VK+ DFGL+R + D Y P+ +
Sbjct: 131 NFIHRDLAARNCLVG----ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWT 179
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 44.7 bits (104), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 22/54 (40%), Positives = 31/54 (57%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
+F+HRDLAARNCLV + +VK+ DFGL+R + D Y P+ +
Sbjct: 133 NFIHRDLAARNCLVG----ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWT 181
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 44.7 bits (104), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 22/54 (40%), Positives = 31/54 (57%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
+F+HRDLAARNCLV + +VK+ DFGL+R + D Y P+ +
Sbjct: 131 NFIHRDLAARNCLVG----ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWT 179
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 44.7 bits (104), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 22/54 (40%), Positives = 31/54 (57%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
+F+HRDLAARNCLV + +VK+ DFGL+R + D Y P+ +
Sbjct: 131 NFIHRDLAARNCLVG----ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWT 179
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 44.7 bits (104), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 22/54 (40%), Positives = 31/54 (57%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
+F+HRDLAARNCLV + +VK+ DFGL+R + D Y P+ +
Sbjct: 133 NFIHRDLAARNCLVG----ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWT 181
>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The
Kinase Domain Of Focal Adhesion Kinase With A
Phosphorylated Activation Loop
Length = 276
Score = 44.7 bits (104), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 25/53 (47%), Positives = 33/53 (62%), Gaps = 5/53 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRD+AARN LVS D VK+GDFGL+R + + K +G LP+ +
Sbjct: 131 RFVHRDIAARNVLVSSND----CVKLGDFGLSRYM-EDSTXXKASKGKLPIKW 178
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 44.3 bits (103), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 24/55 (43%), Positives = 36/55 (65%), Gaps = 5/55 (9%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYR-NDYYKKEGEGLLPVSF 54
H++HR+LAARN L+ R+VKIGDFGLA+ + ++YY+ +G PV +
Sbjct: 136 QHYIHRNLAARNVLLD----NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 186
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 44.3 bits (103), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 24/55 (43%), Positives = 36/55 (65%), Gaps = 5/55 (9%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYR-NDYYKKEGEGLLPVSF 54
H++HR+LAARN L+ R+VKIGDFGLA+ + ++YY+ +G PV +
Sbjct: 136 QHYIHRNLAARNVLLD----NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 186
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 43.9 bits (102), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 23/54 (42%), Positives = 33/54 (61%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
F+HRDLAARNCLV+ +VK+ DFGL+R + ++Y G PV ++
Sbjct: 120 QFLHRDLAARNCLVN----DQGVVKVSDFGLSRYVLDDEYTSSVGSK-FPVRWS 168
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 43.9 bits (102), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 22/54 (40%), Positives = 31/54 (57%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
+F+HRDLAARNCLV + +VK+ DFGL+R + D Y P+ +
Sbjct: 132 NFIHRDLAARNCLVG----ENHLVKVADFGLSR-LMTGDTYTAPAGAKFPIKWT 180
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 43.9 bits (102), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 23/54 (42%), Positives = 33/54 (61%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
F+HRDLAARNCLV+ +VK+ DFGL+R + ++Y G PV ++
Sbjct: 124 QFLHRDLAARNCLVN----DQGVVKVSDFGLSRYVLDDEYTSSVGSK-FPVRWS 172
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 43.9 bits (102), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 23/54 (42%), Positives = 33/54 (61%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
F+HRDLAARNCLV+ +VK+ DFGL+R + ++Y G PV ++
Sbjct: 125 QFLHRDLAARNCLVN----DQGVVKVSDFGLSRYVLDDEYTSSVGSK-FPVRWS 173
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 43.9 bits (102), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 23/54 (42%), Positives = 33/54 (61%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
F+HRDLAARNCLV+ +VK+ DFGL+R + ++Y G PV ++
Sbjct: 140 QFLHRDLAARNCLVN----DQGVVKVSDFGLSRYVLDDEYTSSVGSK-FPVRWS 188
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 43.9 bits (102), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 22/54 (40%), Positives = 31/54 (57%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
+F+HRDLAARNCLV + +VK+ DFGL+R + D Y P+ +
Sbjct: 133 NFIHRDLAARNCLVG----ENHLVKVADFGLSR-LMTGDTYTAPAGAKFPIKWT 181
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 43.9 bits (102), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 23/54 (42%), Positives = 33/54 (61%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
F+HRDLAARNCLV+ +VK+ DFGL+R + ++Y G PV ++
Sbjct: 131 QFLHRDLAARNCLVN----DQGVVKVSDFGLSRYVLDDEYTSSVGSK-FPVRWS 179
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 43.5 bits (101), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 41/90 (45%), Gaps = 19/90 (21%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVI 60
M++VHRDLAA N LV + + K+ DFGLAR I N+Y ++G P+ +
Sbjct: 133 MNYVHRDLAAANILVG----ENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA---- 183
Query: 61 ESKNRSVPFRPELCVYGPLADIDSIKKVGI 90
PE +YG + GI
Sbjct: 184 ----------PEAALYGRFTIKSDVWSFGI 203
>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXP|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 318
Score = 43.5 bits (101), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 24/55 (43%), Positives = 35/55 (63%), Gaps = 5/55 (9%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYR-NDYYKKEGEGLLPVSF 54
H++HRDLAARN L+ R+VKIGDFGLA+ + ++ Y+ +G PV +
Sbjct: 153 QHYIHRDLAARNVLLD----NDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFW 203
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 43.5 bits (101), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 32/79 (40%), Positives = 43/79 (54%), Gaps = 11/79 (13%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVIE 61
F+HR+LAARN LV + + KI DFGL+R + Y K+ G LPV + + IE
Sbjct: 159 QFIHRNLAARNILVG----ENYVAKIADFGLSRG---QEVYVKKTMGRLPVRW---MAIE 208
Query: 62 SKNRSV-PFRPELCVYGPL 79
S N SV ++ YG L
Sbjct: 209 SLNYSVYTTNSDVWSYGVL 227
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 43.5 bits (101), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 21/54 (38%), Positives = 31/54 (57%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
+F+HRDLAARNCLV + +VK+ DFGL+R + D + P+ +
Sbjct: 129 NFIHRDLAARNCLVG----ENHLVKVADFGLSR-LMTGDTFTAHAGAKFPIKWT 177
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 43.1 bits (100), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 24/55 (43%), Positives = 35/55 (63%), Gaps = 5/55 (9%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYR-NDYYKKEGEGLLPVSF 54
H++HR LAARN L+ R+VKIGDFGLA+ + ++YY+ +G PV +
Sbjct: 131 QHYIHRALAARNVLLD----NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 181
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 43.1 bits (100), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 24/55 (43%), Positives = 35/55 (63%), Gaps = 5/55 (9%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYR-NDYYKKEGEGLLPVSF 54
H++HR LAARN L+ R+VKIGDFGLA+ + ++YY+ +G PV +
Sbjct: 130 QHYIHRALAARNVLLD----NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 180
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 43.1 bits (100), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 21/52 (40%), Positives = 31/52 (59%), Gaps = 5/52 (9%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
+HRDLAARNCLV + +++K+ DFG+ R + + Y G PV +A
Sbjct: 125 IHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTK-FPVKWA 171
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 43.1 bits (100), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 21/52 (40%), Positives = 31/52 (59%), Gaps = 5/52 (9%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
+HRDLAARNCLV + +++K+ DFG+ R + + Y G PV +A
Sbjct: 123 IHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTK-FPVKWA 169
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 43.1 bits (100), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 21/52 (40%), Positives = 31/52 (59%), Gaps = 5/52 (9%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
+HRDLAARNCLV + +++K+ DFG+ R + + Y G PV +A
Sbjct: 125 IHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTK-FPVKWA 171
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 43.1 bits (100), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 21/52 (40%), Positives = 31/52 (59%), Gaps = 5/52 (9%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
+HRDLAARNCLV + +++K+ DFG+ R + + Y G PV +A
Sbjct: 126 IHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTK-FPVKWA 172
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 43.1 bits (100), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 21/52 (40%), Positives = 31/52 (59%), Gaps = 5/52 (9%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
+HRDLAARNCLV + +++K+ DFG+ R + + Y G PV +A
Sbjct: 145 IHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTK-FPVKWA 191
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 42.7 bits (99), Expect = 4e-05, Method: Composition-based stats.
Identities = 21/53 (39%), Positives = 31/53 (58%), Gaps = 5/53 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+F+HR+LAARNCLV + +VK+ DFGL+R + D Y P+ +
Sbjct: 338 NFIHRNLAARNCLVG----ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKW 385
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 42.7 bits (99), Expect = 4e-05, Method: Composition-based stats.
Identities = 21/53 (39%), Positives = 31/53 (58%), Gaps = 5/53 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+F+HR+LAARNCLV + +VK+ DFGL+R + D Y P+ +
Sbjct: 377 NFIHRNLAARNCLVG----ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKW 424
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 42.7 bits (99), Expect = 4e-05, Method: Composition-based stats.
Identities = 21/53 (39%), Positives = 31/53 (58%), Gaps = 5/53 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+F+HR+LAARNCLV + +VK+ DFGL+R + D Y P+ +
Sbjct: 335 NFIHRNLAARNCLVG----ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKW 382
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 42.7 bits (99), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 19/33 (57%), Positives = 25/33 (75%), Gaps = 4/33 (12%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+F+HRDLAARNCLV + +VK+ DFGL+R
Sbjct: 132 NFIHRDLAARNCLVG----ENHLVKVADFGLSR 160
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 42.7 bits (99), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 21/52 (40%), Positives = 31/52 (59%), Gaps = 5/52 (9%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
+HRDLAARNCLV + +++K+ DFG+ R + + Y G PV +A
Sbjct: 128 IHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTK-FPVKWA 174
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 42.7 bits (99), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 19/33 (57%), Positives = 25/33 (75%), Gaps = 4/33 (12%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+F+HRDLAARNCLV + +VK+ DFGL+R
Sbjct: 129 NFIHRDLAARNCLVG----ENHLVKVADFGLSR 157
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 42.7 bits (99), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 19/33 (57%), Positives = 25/33 (75%), Gaps = 4/33 (12%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+F+HRDLAARNCLV + +VK+ DFGL+R
Sbjct: 129 NFIHRDLAARNCLVG----ENHLVKVADFGLSR 157
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 42.7 bits (99), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 19/33 (57%), Positives = 25/33 (75%), Gaps = 4/33 (12%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+F+HRDLAARNCLV + +VK+ DFGL+R
Sbjct: 136 NFIHRDLAARNCLVG----ENHLVKVADFGLSR 164
>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2-
Phenylcyclopropyl)urea
Length = 293
Score = 42.7 bits (99), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 23/54 (42%), Positives = 32/54 (59%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND-YYKKEGEGLLPVSF 54
+FVHRDLAARN L+ KI DFGL++ + ++ YYK + G PV +
Sbjct: 147 NFVHRDLAARNVLLVTQ----HYAKISDFGLSKALRADENYYKAQTHGKWPVKW 196
>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Pyrazolylbenzimidazole Inhibitor 416
pdb|3VF9|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Thienopyrazolylindole Inhibitor 027
pdb|3TUC|A Chain A, Crystal Structure Of Syk Kinase Domain With
1-Benzyl-N-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-2-Oxo-1,
2-Dihydropyridine-3- Carboxamide
pdb|3TUD|A Chain A, Crystal Structure Of Syk Kinase Domain With
N-(4-Methyl-3-(8-Methyl-7-
Oxo-2-(Phenylamino)-7,8-Dihydropyrido[2,
3-D]pyrimidin-6-Yl)phenyl)-3- (Trifluoromethyl)benzamide
Length = 299
Score = 42.7 bits (99), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 23/54 (42%), Positives = 32/54 (59%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND-YYKKEGEGLLPVSF 54
+FVHRDLAARN L+ KI DFGL++ + ++ YYK + G PV +
Sbjct: 147 NFVHRDLAARNVLLVTQ----HYAKISDFGLSKALRADENYYKAQTHGKWPVKW 196
>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2-
Phenylaminopyrimidines As Potent Inhibitors Of Spleen
Tyrosine Kinase (Syk)
Length = 291
Score = 42.7 bits (99), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 23/54 (42%), Positives = 32/54 (59%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND-YYKKEGEGLLPVSF 54
+FVHRDLAARN L+ KI DFGL++ + ++ YYK + G PV +
Sbjct: 145 NFVHRDLAARNVLLVTQ----HYAKISDFGLSKALRADENYYKAQTHGKWPVKW 194
>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain
pdb|1XBB|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Gleevec
pdb|1XBC|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Staurosporin
pdb|3FQE|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
Ym193306
pdb|3FQH|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQH|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQS|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
R406
pdb|4FL1|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
pdb|4FYN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
3-(8-{4-
[ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,
2-a]pyrazin-5- Yl)-phenol
pdb|4FYO|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
N-{(s)-1-
[7-(3,4-dimethoxy-phenylamino)-thiazolo[5,
4-d]pyrimidin-5-yl]- Pyrrolidin-3-yl}-terephthalamic
Acid
pdb|4FZ6|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
[6-((s)-2-
Methyl-pyrrolidin-1-yl)-pyridin-2-yl]-(6-phenyl-
imidazo[1,2- B]pyridazin-8-yl)-amine
Length = 291
Score = 42.7 bits (99), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 23/54 (42%), Positives = 32/54 (59%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND-YYKKEGEGLLPVSF 54
+FVHRDLAARN L+ KI DFGL++ + ++ YYK + G PV +
Sbjct: 137 NFVHRDLAARNVLLVTQ----HYAKISDFGLSKALRADENYYKAQTHGKWPVKW 186
>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A Sulfonamidopyrazine Piperidine Inhibitor
pdb|4DFN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
An Adamantylpyrazine Inhibitor
Length = 274
Score = 42.7 bits (99), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 23/54 (42%), Positives = 32/54 (59%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND-YYKKEGEGLLPVSF 54
+FVHRDLAARN L+ KI DFGL++ + ++ YYK + G PV +
Sbjct: 127 NFVHRDLAARNVLLVTQ----HYAKISDFGLSKALRADENYYKAQTHGKWPVKW 176
>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836
Length = 273
Score = 42.4 bits (98), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 23/54 (42%), Positives = 32/54 (59%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND-YYKKEGEGLLPVSF 54
+FVHRDLAARN L+ KI DFGL++ + ++ YYK + G PV +
Sbjct: 125 NFVHRDLAARNVLLVTQ----HYAKISDFGLSKALRADENYYKAQTHGKWPVKW 174
>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 42.4 bits (98), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 23/54 (42%), Positives = 32/54 (59%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND-YYKKEGEGLLPVSF 54
+FVHRDLAARN L+ KI DFGL++ + ++ YYK + G PV +
Sbjct: 131 NFVHRDLAARNVLLVTQ----HYAKISDFGLSKALRADENYYKAQTHGKWPVKW 180
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 42.4 bits (98), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 22/45 (48%), Positives = 28/45 (62%), Gaps = 4/45 (8%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
+++HRDL A N LVS + KI DFGLAR I N+Y +EG
Sbjct: 131 NYIHRDLRAANILVSA----SLVCKIADFGLARVIEDNEYTAREG 171
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 42.4 bits (98), Expect = 6e-05, Method: Composition-based stats.
Identities = 22/45 (48%), Positives = 28/45 (62%), Gaps = 4/45 (8%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
+++HRDL A N LVS + KI DFGLAR I N+Y +EG
Sbjct: 304 NYIHRDLRAANILVSA----SLVCKIADFGLARVIEDNEYTAREG 344
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 42.0 bits (97), Expect = 8e-05, Method: Composition-based stats.
Identities = 29/90 (32%), Positives = 43/90 (47%), Gaps = 24/90 (26%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVIESK 63
+HRDLAARNCLV+ + ++KI DFG++R+ E +G+ S +
Sbjct: 235 IHRDLAARNCLVT----EKNVLKISDFGMSRE---------EADGVXAASGGL------- 274
Query: 64 NRSVPFR---PELCVYGPLADIDSIKKVGI 90
R VP + PE YG + + GI
Sbjct: 275 -RQVPVKWTAPEALNYGRYSSESDVWSFGI 303
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 42.0 bits (97), Expect = 8e-05, Method: Composition-based stats.
Identities = 29/90 (32%), Positives = 43/90 (47%), Gaps = 24/90 (26%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVIESK 63
+HRDLAARNCLV+ + ++KI DFG++R+ E +G+ S +
Sbjct: 235 IHRDLAARNCLVT----EKNVLKISDFGMSRE---------EADGVYAASGGL------- 274
Query: 64 NRSVPFR---PELCVYGPLADIDSIKKVGI 90
R VP + PE YG + + GI
Sbjct: 275 -RQVPVKWTAPEALNYGRYSSESDVWSFGI 303
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 42.0 bits (97), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 22/45 (48%), Positives = 29/45 (64%), Gaps = 4/45 (8%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
+++HRDL A N LVS + + KI DFGLAR I N+Y +EG
Sbjct: 129 NYIHRDLRAANVLVS----ESLMCKIADFGLARVIEDNEYTAREG 169
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 42.0 bits (97), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 22/40 (55%), Positives = 27/40 (67%), Gaps = 4/40 (10%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYK 43
VHRD+A RN LV+ + VK+GDFGL+R I DYYK
Sbjct: 147 VHRDIAVRNILVASPE----CVKLGDFGLSRYIEDEDYYK 182
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 41.6 bits (96), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 22/40 (55%), Positives = 27/40 (67%), Gaps = 4/40 (10%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYK 43
VHRD+A RN LV+ + VK+GDFGL+R I DYYK
Sbjct: 131 VHRDIAVRNILVASPE----CVKLGDFGLSRYIEDEDYYK 166
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 41.6 bits (96), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 22/40 (55%), Positives = 27/40 (67%), Gaps = 4/40 (10%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYK 43
VHRD+A RN LV+ + VK+GDFGL+R I DYYK
Sbjct: 135 VHRDIAVRNILVASPE----CVKLGDFGLSRYIEDEDYYK 170
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 41.6 bits (96), Expect = 1e-04, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 29/46 (63%), Gaps = 4/46 (8%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
M++VHRDL A N LV + + K+ DFGLAR I N+Y ++G
Sbjct: 299 MNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQG 340
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 41.6 bits (96), Expect = 1e-04, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 29/46 (63%), Gaps = 4/46 (8%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
M++VHRDL A N LV + + K+ DFGLAR I N+Y ++G
Sbjct: 299 MNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQG 340
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 41.6 bits (96), Expect = 1e-04, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 29/46 (63%), Gaps = 4/46 (8%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
M++VHRDL A N LV + + K+ DFGLAR I N+Y ++G
Sbjct: 299 MNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQG 340
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 41.6 bits (96), Expect = 1e-04, Method: Composition-based stats.
Identities = 21/46 (45%), Positives = 29/46 (63%), Gaps = 4/46 (8%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
M++VHRDL A N LV + + K+ DFGLAR I N+Y ++G
Sbjct: 382 MNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQG 423
>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 635
Score = 41.6 bits (96), Expect = 1e-04, Method: Composition-based stats.
Identities = 23/54 (42%), Positives = 32/54 (59%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND-YYKKEGEGLLPVSF 54
+FVHRDLAARN L+ KI DFGL++ + ++ YYK + G PV +
Sbjct: 489 NFVHRDLAARNVLLV----TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 538
>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 636
Score = 41.6 bits (96), Expect = 1e-04, Method: Composition-based stats.
Identities = 23/54 (42%), Positives = 32/54 (59%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND-YYKKEGEGLLPVSF 54
+FVHRDLAARN L+ KI DFGL++ + ++ YYK + G PV +
Sbjct: 490 NFVHRDLAARNVLLV----TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 539
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 41.6 bits (96), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 22/45 (48%), Positives = 29/45 (64%), Gaps = 4/45 (8%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
+++HRDL A N LVS + + KI DFGLAR I N+Y +EG
Sbjct: 130 NYIHRDLRAANVLVS----ESLMCKIADFGLARVIEDNEYTAREG 170
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 41.6 bits (96), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 40/90 (44%), Gaps = 19/90 (21%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVI 60
M++VHRDL A N LV + + K+ DFGLAR I N+Y ++G P+ +
Sbjct: 130 MNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA---- 180
Query: 61 ESKNRSVPFRPELCVYGPLADIDSIKKVGI 90
PE +YG + GI
Sbjct: 181 ----------PEAALYGRFTIKSDVWSFGI 200
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 41.6 bits (96), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 40/90 (44%), Gaps = 19/90 (21%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVI 60
M++VHRDL A N LV + + K+ DFGLAR I N+Y ++G P+ +
Sbjct: 126 MNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA---- 176
Query: 61 ESKNRSVPFRPELCVYGPLADIDSIKKVGI 90
PE +YG + GI
Sbjct: 177 ----------PEAALYGRFTIKSDVWSFGI 196
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 41.6 bits (96), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 40/90 (44%), Gaps = 19/90 (21%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVI 60
M++VHRDL A N LV + + K+ DFGLAR I N+Y ++G P+ +
Sbjct: 122 MNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA---- 172
Query: 61 ESKNRSVPFRPELCVYGPLADIDSIKKVGI 90
PE +YG + GI
Sbjct: 173 ----------PEAALYGRFTIKSDVWSFGI 192
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 41.6 bits (96), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 40/90 (44%), Gaps = 19/90 (21%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVI 60
M++VHRDL A N LV + + K+ DFGLAR I N+Y ++G P+ +
Sbjct: 133 MNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA---- 183
Query: 61 ESKNRSVPFRPELCVYGPLADIDSIKKVGI 90
PE +YG + GI
Sbjct: 184 ----------PEAALYGRFTIKSDVWSFGI 203
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 41.6 bits (96), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 40/90 (44%), Gaps = 19/90 (21%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVI 60
M++VHRDL A N LV + + K+ DFGLAR I N+Y ++G P+ +
Sbjct: 133 MNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA---- 183
Query: 61 ESKNRSVPFRPELCVYGPLADIDSIKKVGI 90
PE +YG + GI
Sbjct: 184 ----------PEAALYGRFTIKSDVWSFGI 203
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 41.6 bits (96), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 40/90 (44%), Gaps = 19/90 (21%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVI 60
M++VHRDL A N LV + + K+ DFGLAR I N+Y ++G P+ +
Sbjct: 133 MNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA---- 183
Query: 61 ESKNRSVPFRPELCVYGPLADIDSIKKVGI 90
PE +YG + GI
Sbjct: 184 ----------PEAALYGRFTIKSDVWSFGI 203
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 41.2 bits (95), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 40/90 (44%), Gaps = 19/90 (21%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVI 60
M++VHRDL A N LV + + K+ DFGLAR I N+Y ++G P+ +
Sbjct: 124 MNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA---- 174
Query: 61 ESKNRSVPFRPELCVYGPLADIDSIKKVGI 90
PE +YG + GI
Sbjct: 175 ----------PEAALYGRFTIKSDVWSFGI 194
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 41.2 bits (95), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 19/33 (57%), Positives = 24/33 (72%), Gaps = 4/33 (12%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
F+HRDLAARNCLV+ +VK+ DFGL+R
Sbjct: 140 QFLHRDLAARNCLVN----DQGVVKVSDFGLSR 168
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 41.2 bits (95), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 40/90 (44%), Gaps = 19/90 (21%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVI 60
M++VHRDL A N LV + + K+ DFGLAR I N+Y ++G P+ +
Sbjct: 133 MNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA---- 183
Query: 61 ESKNRSVPFRPELCVYGPLADIDSIKKVGI 90
PE +YG + GI
Sbjct: 184 ----------PEAALYGRFTIKSDVWSFGI 203
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 41.2 bits (95), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 40/90 (44%), Gaps = 19/90 (21%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVI 60
M++VHRDL A N LV + + K+ DFGLAR I N+Y ++G P+ +
Sbjct: 133 MNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA---- 183
Query: 61 ESKNRSVPFRPELCVYGPLADIDSIKKVGI 90
PE +YG + GI
Sbjct: 184 ----------PEAALYGRFTIKSDVWSFGI 203
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 41.2 bits (95), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 40/90 (44%), Gaps = 19/90 (21%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVI 60
M++VHRDL A N LV + + K+ DFGLAR I N+Y ++G P+ +
Sbjct: 133 MNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTA---- 183
Query: 61 ESKNRSVPFRPELCVYGPLADIDSIKKVGI 90
PE +YG + GI
Sbjct: 184 ----------PEAALYGRFTIKSDVWSFGI 203
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 40.4 bits (93), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 40/90 (44%), Gaps = 19/90 (21%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVI 60
M++VHRDL A N LV + + K+ DFGLAR I N++ ++G P+ +
Sbjct: 130 MNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEWTARQG-AKFPIKWTA---- 180
Query: 61 ESKNRSVPFRPELCVYGPLADIDSIKKVGI 90
PE +YG + GI
Sbjct: 181 ----------PEAALYGRFTIKSDVWSFGI 200
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 40.4 bits (93), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 25/49 (51%), Positives = 30/49 (61%), Gaps = 6/49 (12%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR--DIYRNDYYKKEGE 47
+ VHRDLAARN LV P + VKI DFGLAR DI +Y+ G+
Sbjct: 138 VRLVHRDLAARNVLVKS--PNH--VKITDFGLARLLDIDETEYHADGGK 182
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 40.0 bits (92), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 22/54 (40%), Positives = 30/54 (55%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
F+HRDLAARNCLV + VK+ DFG+ R + + Y G PV ++
Sbjct: 124 QFIHRDLAARNCLVD----RDLCVKVSDFGMTRYVLDDQYVSSVGTK-FPVKWS 172
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 40.0 bits (92), Expect = 3e-04, Method: Composition-based stats.
Identities = 20/46 (43%), Positives = 28/46 (60%), Gaps = 4/46 (8%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
M++VHRDL A N LV + + K+ DFGL R I N+Y ++G
Sbjct: 300 MNYVHRDLRAANILVG----ENLVCKVADFGLGRLIEDNEYTARQG 341
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 40.0 bits (92), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 24/66 (36%), Positives = 33/66 (50%), Gaps = 9/66 (13%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVIE 61
+FVHRDLAARN LVS + + K+ DFGL ++ + G LPV + +
Sbjct: 122 NFVHRDLAARNVLVS----EDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALR 172
Query: 62 SKNRSV 67
K S
Sbjct: 173 EKKFST 178
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 40.0 bits (92), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 24/66 (36%), Positives = 33/66 (50%), Gaps = 9/66 (13%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVIE 61
+FVHRDLAARN LVS + + K+ DFGL ++ + G LPV + +
Sbjct: 137 NFVHRDLAARNVLVS----EDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALR 187
Query: 62 SKNRSV 67
K S
Sbjct: 188 EKKFST 193
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 39.7 bits (91), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 22/45 (48%), Positives = 27/45 (60%), Gaps = 4/45 (8%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
+++HRDL A N LVS KI DFGLAR I N+Y +EG
Sbjct: 135 NYIHRDLRAANILVS----DTLSCKIADFGLARLIEDNEYTAREG 175
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 39.7 bits (91), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 22/45 (48%), Positives = 27/45 (60%), Gaps = 4/45 (8%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
+++HRDL A N LVS KI DFGLAR I N+Y +EG
Sbjct: 139 NYIHRDLRAANILVS----DTLSCKIADFGLARLIEDNEYTAREG 179
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 39.7 bits (91), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 22/45 (48%), Positives = 27/45 (60%), Gaps = 4/45 (8%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
+++HRDL A N LVS KI DFGLAR I N+Y +EG
Sbjct: 134 NYIHRDLRAANILVS----DTLSCKIADFGLARLIEDNEYTAREG 174
>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex
With Staurosporine
Length = 287
Score = 39.7 bits (91), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 28/77 (36%), Positives = 40/77 (51%), Gaps = 7/77 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND-YYKKEGEGLLPVSFAITVVI 60
+FVHRDLAARN L+ ++ Y KI DFGL++ + +D YY G P+ + I
Sbjct: 130 NFVHRDLAARNVLL--VNRHY--AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185
Query: 61 ESKNRSVPFRPELCVYG 77
R R ++ YG
Sbjct: 186 NF--RKFSSRSDVWSYG 200
>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 39.7 bits (91), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 22/54 (40%), Positives = 31/54 (57%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND-YYKKEGEGLLPVSF 54
+FVHRDLAARN L+ KI DFGL++ + ++ YK + G PV +
Sbjct: 131 NFVHRDLAARNVLLVTQ----HYAKISDFGLSKALRADENXYKAQTHGKWPVKW 180
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 39.7 bits (91), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 22/45 (48%), Positives = 27/45 (60%), Gaps = 4/45 (8%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
+++HRDL A N LVS KI DFGLAR I N+Y +EG
Sbjct: 129 NYIHRDLRAANILVS----DTLSCKIADFGLARLIEDNEYTAREG 169
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 39.7 bits (91), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 22/45 (48%), Positives = 27/45 (60%), Gaps = 4/45 (8%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
+++HRDL A N LVS KI DFGLAR I N+Y +EG
Sbjct: 124 NYIHRDLRAANILVS----DTLSCKIADFGLARLIEDNEYTAREG 164
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 38.9 bits (89), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 23/52 (44%), Positives = 30/52 (57%), Gaps = 4/52 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P + VKI DFGLAR + ++ G +P+ +
Sbjct: 161 LVHRDLAARNVLVKS--PNH--VKITDFGLARLLEGDEKEYNADGGKMPIKW 208
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 38.9 bits (89), Expect = 7e-04, Method: Composition-based stats.
Identities = 24/65 (36%), Positives = 33/65 (50%), Gaps = 9/65 (13%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVIE 61
+FVHRDLAARN LVS + + K+ DFGL ++ + G LPV + +
Sbjct: 309 NFVHRDLAARNVLVS----EDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALR 359
Query: 62 SKNRS 66
K S
Sbjct: 360 EKKFS 364
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 38.9 bits (89), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 23/52 (44%), Positives = 30/52 (57%), Gaps = 4/52 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P + VKI DFGLAR + ++ G +P+ +
Sbjct: 138 LVHRDLAARNVLVKS--PNH--VKITDFGLARLLEGDEKEYNADGGKMPIKW 185
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 38.9 bits (89), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 22/54 (40%), Positives = 30/54 (55%), Gaps = 9/54 (16%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFA 55
+FVHRDLAARN LVS + + K+ DFGL ++ + G LPV +
Sbjct: 128 NFVHRDLAARNVLVS----EDNVAKVSDFGLTKEASST-----QDTGKLPVKWT 172
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 38.5 bits (88), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 39/90 (43%), Gaps = 19/90 (21%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVI 60
M++VHRDL A N LV + + K+ DFGLAR I N+ ++G P+ +
Sbjct: 123 MNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEXTARQG-AKFPIKWTA---- 173
Query: 61 ESKNRSVPFRPELCVYGPLADIDSIKKVGI 90
PE +YG + GI
Sbjct: 174 ----------PEAALYGRFTIKSDVWSFGI 193
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 38.5 bits (88), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 20/35 (57%), Positives = 22/35 (62%), Gaps = 4/35 (11%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
+VHRDLAARN LV VKIGDFGL + I
Sbjct: 146 QYVHRDLAARNVLVES----EHQVKIGDFGLTKAI 176
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 38.5 bits (88), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 39/90 (43%), Gaps = 19/90 (21%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVI 60
M++VHRDL A N LV + + K+ DFGLAR I N+ ++G P+ +
Sbjct: 133 MNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEXTARQG-AKFPIKWTA---- 183
Query: 61 ESKNRSVPFRPELCVYGPLADIDSIKKVGI 90
PE +YG + GI
Sbjct: 184 ----------PEAALYGRFTIKSDVWSFGI 203
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 38.1 bits (87), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 20/35 (57%), Positives = 22/35 (62%), Gaps = 4/35 (11%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
+VHRDLAARN LV VKIGDFGL + I
Sbjct: 134 QYVHRDLAARNVLVES----EHQVKIGDFGLTKAI 164
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 38.1 bits (87), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/53 (47%), Positives = 32/53 (60%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFGLA+ + Y EG G +P+ +
Sbjct: 138 LVHRDLAARNVLVKT--PQH--VKITDFGLAKLLGAEEKEYHAEG-GKVPIKW 185
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 38.1 bits (87), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/53 (47%), Positives = 32/53 (60%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFGLA+ + Y EG G +P+ +
Sbjct: 139 LVHRDLAARNVLVKT--PQH--VKITDFGLAKLLGAEEKEYHAEG-GKVPIKW 186
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 38.1 bits (87), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 23/64 (35%), Positives = 34/64 (53%), Gaps = 7/64 (10%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR---DIYRNDYYKKEGEGLLPVSFAIT 57
M++VHRDLAARN LV+ + K+ DFGL+R D + Y G +P+ +
Sbjct: 154 MNYVHRDLAARNILVNS----NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 209
Query: 58 VVIE 61
I+
Sbjct: 210 EAIQ 213
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 38.1 bits (87), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/53 (47%), Positives = 32/53 (60%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFGLA+ + Y EG G +P+ +
Sbjct: 148 LVHRDLAARNVLVKT--PQH--VKITDFGLAKLLGAEEKEYHAEG-GKVPIKW 195
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 38.1 bits (87), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/53 (47%), Positives = 32/53 (60%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFGLA+ + Y EG G +P+ +
Sbjct: 144 LVHRDLAARNVLVKT--PQH--VKITDFGLAKLLGAEEKEYHAEG-GKVPIKW 191
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 38.1 bits (87), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/53 (47%), Positives = 32/53 (60%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFGLA+ + Y EG G +P+ +
Sbjct: 140 LVHRDLAARNVLVKT--PQH--VKITDFGLAKLLGAEEKEYHAEG-GKVPIKW 187
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 38.1 bits (87), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/53 (47%), Positives = 32/53 (60%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFGLA+ + Y EG G +P+ +
Sbjct: 145 LVHRDLAARNVLVKT--PQH--VKITDFGLAKLLGAEEKEYHAEG-GKVPIKW 192
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 38.1 bits (87), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/53 (47%), Positives = 32/53 (60%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFGLA+ + Y EG G +P+ +
Sbjct: 138 LVHRDLAARNVLVKT--PQH--VKITDFGLAKLLGAEEKEYHAEG-GKVPIKW 185
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 38.1 bits (87), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 22/58 (37%), Positives = 31/58 (53%), Gaps = 7/58 (12%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND---YYKKEGEGLLPVSFA 55
M +VHRDLAARN LV+ + K+ DFGL+R + N Y G +P+ +
Sbjct: 135 MSYVHRDLAARNILVNS----NLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWT 188
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 38.1 bits (87), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/53 (47%), Positives = 32/53 (60%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFGLA+ + Y EG G +P+ +
Sbjct: 145 LVHRDLAARNVLVKT--PQH--VKITDFGLAKLLGAEEKEYHAEG-GKVPIKW 192
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 38.1 bits (87), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/53 (47%), Positives = 32/53 (60%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFGLA+ + Y EG G +P+ +
Sbjct: 138 LVHRDLAARNVLVKT--PQH--VKITDFGLAKLLGAEEKEYHAEG-GKVPIKW 185
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 38.1 bits (87), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/53 (47%), Positives = 32/53 (60%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFGLA+ + Y EG G +P+ +
Sbjct: 135 LVHRDLAARNVLVKT--PQH--VKITDFGLAKLLGAEEKEYHAEG-GKVPIKW 182
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 38.1 bits (87), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/53 (47%), Positives = 32/53 (60%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFGLA+ + Y EG G +P+ +
Sbjct: 145 LVHRDLAARNVLVKT--PQH--VKITDFGLAKLLGAEEKEYHAEG-GKVPIKW 192
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 38.1 bits (87), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/53 (47%), Positives = 32/53 (60%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFGLA+ + Y EG G +P+ +
Sbjct: 138 LVHRDLAARNVLVKT--PQH--VKITDFGLAKLLGAEEKEYHAEG-GKVPIKW 185
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 38.1 bits (87), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/53 (47%), Positives = 32/53 (60%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFGLA+ + Y EG G +P+ +
Sbjct: 141 LVHRDLAARNVLVKT--PQH--VKITDFGLAKLLGAEEKEYHAEG-GKVPIKW 188
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 38.1 bits (87), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/53 (47%), Positives = 32/53 (60%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFGLA+ + Y EG G +P+ +
Sbjct: 139 LVHRDLAARNVLVKT--PQH--VKITDFGLAKLLGAEEKEYHAEG-GKVPIKW 186
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 38.1 bits (87), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/53 (47%), Positives = 32/53 (60%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFGLA+ + Y EG G +P+ +
Sbjct: 138 LVHRDLAARNVLVKT--PQH--VKITDFGLAKLLGAEEKEYHAEG-GKVPIKW 185
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 38.1 bits (87), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/53 (47%), Positives = 32/53 (60%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFGLA+ + Y EG G +P+ +
Sbjct: 141 LVHRDLAARNVLVKT--PQH--VKITDFGLAKLLGAEEKEYHAEG-GKVPIKW 188
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 38.1 bits (87), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/53 (47%), Positives = 32/53 (60%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFGLA+ + Y EG G +P+ +
Sbjct: 141 LVHRDLAARNVLVKT--PQH--VKITDFGLAKLLGAEEKEYHAEG-GKVPIKW 188
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 38.1 bits (87), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/53 (47%), Positives = 32/53 (60%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFGLA+ + Y EG G +P+ +
Sbjct: 141 LVHRDLAARNVLVKT--PQH--VKITDFGLAKLLGAEEKEYHAEG-GKVPIKW 188
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 38.1 bits (87), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/53 (47%), Positives = 32/53 (60%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFGLA+ + Y EG G +P+ +
Sbjct: 140 LVHRDLAARNVLVKT--PQH--VKITDFGLAKLLGAEEKEYHAEG-GKVPIKW 187
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 38.1 bits (87), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/53 (47%), Positives = 32/53 (60%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFGLA+ + Y EG G +P+ +
Sbjct: 142 LVHRDLAARNVLVKT--PQH--VKITDFGLAKLLGAEEKEYHAEG-GKVPIKW 189
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 38.1 bits (87), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 21/49 (42%), Positives = 27/49 (55%), Gaps = 4/49 (8%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGL 49
M +VHRDLAARN LV+ + K+ DFGL+R + N E L
Sbjct: 137 MSYVHRDLAARNILVNS----NLVCKVSDFGLSRFLEENSSDPTETSSL 181
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 38.1 bits (87), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/53 (47%), Positives = 32/53 (60%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFGLA+ + Y EG G +P+ +
Sbjct: 132 LVHRDLAARNVLVKT--PQH--VKITDFGLAKLLGAEEKEYHAEG-GKVPIKW 179
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 38.1 bits (87), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 25/53 (47%), Positives = 32/53 (60%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFGLA+ + Y EG G +P+ +
Sbjct: 163 LVHRDLAARNVLVKT--PQH--VKITDFGLAKLLGAEEKEYHAEG-GKVPIKW 210
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 37.7 bits (86), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 21/45 (46%), Positives = 27/45 (60%), Gaps = 4/45 (8%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
+++HR+L A N LVS KI DFGLAR I N+Y +EG
Sbjct: 125 NYIHRNLRAANILVS----DTLSCKIADFGLARLIEDNEYTAREG 165
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 37.7 bits (86), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 25/63 (39%), Positives = 38/63 (60%), Gaps = 6/63 (9%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRN-DYYKKEGEGLLPV-SFAITVVI 60
++HR+LA RN LV + VKIGDFGL + + ++ +YYK + G P+ +A +
Sbjct: 136 YIHRNLATRNILVENENR----VKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 191
Query: 61 ESK 63
ESK
Sbjct: 192 ESK 194
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 37.4 bits (85), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 18/34 (52%), Positives = 24/34 (70%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
M++VHRDLAARN LV+ + K+ DFGL+R
Sbjct: 166 MNYVHRDLAARNILVNS----NLVCKVSDFGLSR 195
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 37.0 bits (84), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 18/34 (52%), Positives = 23/34 (67%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
M FVHRDLAARN L++ + K+ DFGL+R
Sbjct: 166 MGFVHRDLAARNILINS----NLVCKVSDFGLSR 195
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 37.0 bits (84), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 38/90 (42%), Gaps = 19/90 (21%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVI 60
M+++HRDL + N LV I KI DFGLAR I N+ ++G P+ +
Sbjct: 124 MNYIHRDLRSANILVG----NGLICKIADFGLARLIEDNEXTARQG-AKFPIKWTA---- 174
Query: 61 ESKNRSVPFRPELCVYGPLADIDSIKKVGI 90
PE +YG + GI
Sbjct: 175 ----------PEAALYGRFTIKSDVWSFGI 194
>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70
Length = 613
Score = 37.0 bits (84), Expect = 0.003, Method: Composition-based stats.
Identities = 22/54 (40%), Positives = 33/54 (61%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND-YYKKEGEGLLPVSF 54
+FVHR+LAARN L+ ++ Y KI DFGL++ + +D YY G P+ +
Sbjct: 456 NFVHRNLAARNVLL--VNRHY--AKISDFGLSKALGADDSYYTARSAGKWPLKW 505
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 36.6 bits (83), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 21/45 (46%), Positives = 26/45 (57%), Gaps = 4/45 (8%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
+++HRDL A N LVS KI DFGLAR I N+ +EG
Sbjct: 138 NYIHRDLRAANILVS----DTLSCKIADFGLARLIEDNEXTAREG 178
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 36.6 bits (83), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 18/34 (52%), Positives = 23/34 (67%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
M +VHRDLAARN L++ + K+ DFGLAR
Sbjct: 166 MGYVHRDLAARNILINS----NLVCKVSDFGLAR 195
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 36.6 bits (83), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 21/45 (46%), Positives = 26/45 (57%), Gaps = 4/45 (8%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
+++HRDL A N LVS KI DFGLAR I N+ +EG
Sbjct: 135 NYIHRDLRAANILVS----DTLSCKIADFGLARLIEDNEXTAREG 175
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 36.6 bits (83), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 21/45 (46%), Positives = 26/45 (57%), Gaps = 4/45 (8%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
+++HRDL A N LVS KI DFGLAR I N+ +EG
Sbjct: 137 NYIHRDLRAANILVS----DTLSCKIADFGLARLIEDNEXTAREG 177
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 36.6 bits (83), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 21/45 (46%), Positives = 26/45 (57%), Gaps = 4/45 (8%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
+++HRDL A N LVS KI DFGLAR I N+ +EG
Sbjct: 131 NYIHRDLRAANILVS----DTLSCKIADFGLARLIEDNEXTAREG 171
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 36.6 bits (83), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 21/45 (46%), Positives = 26/45 (57%), Gaps = 4/45 (8%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
+++HRDL A N LVS KI DFGLAR I N+ +EG
Sbjct: 130 NYIHRDLRAANILVS----DTLSCKIADFGLARLIEDNEXTAREG 170
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 36.6 bits (83), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 21/45 (46%), Positives = 26/45 (57%), Gaps = 4/45 (8%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
+++HRDL A N LVS KI DFGLAR I N+ +EG
Sbjct: 129 NYIHRDLRAANILVS----DTLSCKIADFGLARLIEDNEXTAREG 169
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 36.6 bits (83), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 21/45 (46%), Positives = 26/45 (57%), Gaps = 4/45 (8%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
+++HRDL A N LVS KI DFGLAR I N+ +EG
Sbjct: 129 NYIHRDLRAANILVS----DTLSCKIADFGLARLIEDNEXTAREG 169
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 36.6 bits (83), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 24/63 (38%), Positives = 38/63 (60%), Gaps = 6/63 (9%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRN-DYYKKEGEGLLPV-SFAITVVI 60
++HRDLA RN LV + VKIGDFGL + + ++ +++K + G P+ +A +
Sbjct: 135 YIHRDLATRNILVENENR----VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 61 ESK 63
ESK
Sbjct: 191 ESK 193
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 36.6 bits (83), Expect = 0.004, Method: Composition-based stats.
Identities = 25/53 (47%), Positives = 32/53 (60%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFGLA+ + Y EG G +P+ +
Sbjct: 172 LVHRDLAARNVLVKT--PQH--VKITDFGLAKLLGAEEKEYHAEG-GKVPIKW 219
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 36.2 bits (82), Expect = 0.004, Method: Composition-based stats.
Identities = 17/34 (50%), Positives = 23/34 (67%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
M +VHRDLAARN L++ + K+ DFGL+R
Sbjct: 137 MGYVHRDLAARNILIN----SNLVCKVSDFGLSR 166
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 36.2 bits (82), Expect = 0.004, Method: Composition-based stats.
Identities = 17/34 (50%), Positives = 23/34 (67%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
M +VHRDLAARN L++ + K+ DFGL+R
Sbjct: 137 MGYVHRDLAARNILIN----SNLVCKVSDFGLSR 166
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 35.8 bits (81), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 17/34 (50%), Positives = 23/34 (67%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
M +VHRDLAARN L++ + K+ DFGL+R
Sbjct: 154 MGYVHRDLAARNILINS----NLVCKVSDFGLSR 183
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 35.8 bits (81), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 25/66 (37%), Positives = 35/66 (53%), Gaps = 7/66 (10%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRN--DYYKKEGEGLLPVSFAITV 58
M +VHRDLAARN LV+ + K+ DFGL+R I + Y G G +PV +
Sbjct: 164 MGYVHRDLAARNILVNS----NLVCKVSDFGLSRVIEDDPEAVYTTTG-GKIPVRWTAPE 218
Query: 59 VIESKN 64
I+ +
Sbjct: 219 AIQYRK 224
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 35.8 bits (81), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 17/34 (50%), Positives = 23/34 (67%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
M +VHRDLAARN L++ + K+ DFGL+R
Sbjct: 164 MGYVHRDLAARNILINS----NLVCKVSDFGLSR 193
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 35.8 bits (81), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 17/34 (50%), Positives = 23/34 (67%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
M +VHRDLAARN L++ + K+ DFGL+R
Sbjct: 166 MGYVHRDLAARNILINS----NLVCKVSDFGLSR 195
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 35.8 bits (81), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 17/34 (50%), Positives = 23/34 (67%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
M +VHRDLAARN L++ + K+ DFGL+R
Sbjct: 166 MGYVHRDLAARNILINS----NLVCKVSDFGLSR 195
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 35.8 bits (81), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 17/34 (50%), Positives = 23/34 (67%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
M +VHRDLAARN L++ + K+ DFGL+R
Sbjct: 166 MGYVHRDLAARNILINS----NLVCKVSDFGLSR 195
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 35.8 bits (81), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 17/34 (50%), Positives = 23/34 (67%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
M +VHRDLAARN L++ + K+ DFGL+R
Sbjct: 166 MGYVHRDLAARNILINS----NLVCKVSDFGLSR 195
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 35.8 bits (81), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 17/34 (50%), Positives = 23/34 (67%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
M +VHRDLAARN L++ + K+ DFGL+R
Sbjct: 166 MGYVHRDLAARNILINS----NLVCKVSDFGLSR 195
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 35.4 bits (80), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 17/34 (50%), Positives = 23/34 (67%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
M +VHRDLAARN L++ + K+ DFGL+R
Sbjct: 143 MGYVHRDLAARNILINS----NLVCKVSDFGLSR 172
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 35.4 bits (80), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 24/53 (45%), Positives = 31/53 (58%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFG A+ + Y EG G +P+ +
Sbjct: 142 LVHRDLAARNVLVKT--PQH--VKITDFGRAKLLGAEEKEYHAEG-GKVPIKW 189
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 35.4 bits (80), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 24/53 (45%), Positives = 31/53 (58%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFG A+ + Y EG G +P+ +
Sbjct: 138 LVHRDLAARNVLVKT--PQH--VKITDFGRAKLLGAEEKEYHAEG-GKVPIKW 185
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 35.4 bits (80), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 24/53 (45%), Positives = 31/53 (58%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFG A+ + Y EG G +P+ +
Sbjct: 145 LVHRDLAARNVLVKT--PQH--VKITDFGRAKLLGAEEKEYHAEG-GKVPIKW 192
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 35.4 bits (80), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 24/53 (45%), Positives = 31/53 (58%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFG A+ + Y EG G +P+ +
Sbjct: 140 LVHRDLAARNVLVKT--PQH--VKITDFGRAKLLGAEEKEYHAEG-GKVPIKW 187
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 35.4 bits (80), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 24/53 (45%), Positives = 31/53 (58%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFG A+ + Y EG G +P+ +
Sbjct: 140 LVHRDLAARNVLVKT--PQH--VKITDFGRAKLLGAEEKEYHAEG-GKVPIKW 187
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 35.4 bits (80), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 24/53 (45%), Positives = 31/53 (58%), Gaps = 6/53 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFG A+ + Y EG G +P+ +
Sbjct: 140 LVHRDLAARNVLVKT--PQH--VKITDFGRAKLLGAEEKEYHAEG-GKVPIKW 187
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 35.4 bits (80), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 17/34 (50%), Positives = 23/34 (67%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
M +VHRDLAARN LV+ + K+ DFG++R
Sbjct: 129 MSYVHRDLAARNILVNS----NLVCKVSDFGMSR 158
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 35.4 bits (80), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 17/34 (50%), Positives = 23/34 (67%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
M +VHRDLAARN LV+ + K+ DFG++R
Sbjct: 135 MSYVHRDLAARNILVNS----NLVCKVSDFGMSR 164
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 35.4 bits (80), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 17/34 (50%), Positives = 22/34 (64%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
M +VHRDLAARN L++ + K+ DFGL R
Sbjct: 166 MGYVHRDLAARNILINS----NLVCKVSDFGLGR 195
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 35.0 bits (79), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 17/32 (53%), Positives = 22/32 (68%), Gaps = 1/32 (3%)
Query: 4 VHRDLAARNCLVSCLDPKYR-IVKIGDFGLAR 34
+HRDL +N L+S D ++KIGDFGLAR
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-1,2,2-trimethyl-propyl)-amide
pdb|4HVG|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-2-hydroxy-1,2-dimethyl-propyl)- Amide
pdb|4HVH|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-2-hydroxy-1,2-dimethyl-propyl
pdb|4HVI|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-1-methyl-2-oxo-2-piperidin-1-yl- Ethyl)-amide
Length = 314
Score = 35.0 bits (79), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 24/50 (48%), Positives = 27/50 (54%), Gaps = 5/50 (10%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPV 52
VHRDLAARN LV VKI DFGLA+ + DYY G P+
Sbjct: 136 VHRDLAARNILVE----SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 181
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 35.0 bits (79), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 22/64 (34%), Positives = 33/64 (51%), Gaps = 7/64 (10%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR---DIYRNDYYKKEGEGLLPVSFAIT 57
M++VHR LAARN LV+ + K+ DFGL+R D + Y G +P+ +
Sbjct: 128 MNYVHRALAARNILVNS----NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 183
Query: 58 VVIE 61
I+
Sbjct: 184 EAIQ 187
>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXL|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 327
Score = 35.0 bits (79), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 24/50 (48%), Positives = 27/50 (54%), Gaps = 5/50 (10%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPV 52
VHRDLAARN LV VKI DFGLA+ + DYY G P+
Sbjct: 149 VHRDLAARNILVE----SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 194
>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site
Inhibitor Showing High Selectivity Within The Janus
Kinase Family
Length = 315
Score = 35.0 bits (79), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 24/50 (48%), Positives = 27/50 (54%), Gaps = 5/50 (10%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPV 52
VHRDLAARN LV VKI DFGLA+ + DYY G P+
Sbjct: 137 VHRDLAARNILVE----SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 182
>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY4|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY5|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp.
pdb|1ZY5|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp
Length = 303
Score = 35.0 bits (79), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 22/58 (37%), Positives = 33/58 (56%), Gaps = 5/58 (8%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRN-DYYKKEGEGLLPVSFAITVVI 60
+HRDL N + + R VKIGDFGLA++++R+ D K + + L S +T I
Sbjct: 138 IHRDLKPMNIFID----ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 35.0 bits (79), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 19/47 (40%), Positives = 25/47 (53%), Gaps = 4/47 (8%)
Query: 4 VHRDLAARNCL----VSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
+HRDL + N L V D +I+KI DFGLAR+ +R G
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAG 176
>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYD|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp.
pdb|1ZYD|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp
Length = 303
Score = 35.0 bits (79), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 22/58 (37%), Positives = 33/58 (56%), Gaps = 5/58 (8%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRN-DYYKKEGEGLLPVSFAITVVI 60
+HRDL N + + R VKIGDFGLA++++R+ D K + + L S +T I
Sbjct: 138 IHRDLKPMNIFID----ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 35.0 bits (79), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 17/32 (53%), Positives = 21/32 (65%), Gaps = 4/32 (12%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
++HRDLA RN LV + VKIGDFGL +
Sbjct: 153 YIHRDLATRNILVENENR----VKIGDFGLTK 180
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 35.0 bits (79), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 17/32 (53%), Positives = 21/32 (65%), Gaps = 4/32 (12%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
++HRDLA RN LV + VKIGDFGL +
Sbjct: 166 YIHRDLATRNILVENENR----VKIGDFGLTK 193
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 35.0 bits (79), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 17/32 (53%), Positives = 21/32 (65%), Gaps = 4/32 (12%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
++HRDLA RN LV + VKIGDFGL +
Sbjct: 133 YIHRDLATRNILVENENR----VKIGDFGLTK 160
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 35.0 bits (79), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 17/32 (53%), Positives = 21/32 (65%), Gaps = 4/32 (12%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
++HRDLA RN LV + VKIGDFGL +
Sbjct: 134 YIHRDLATRNILVENENR----VKIGDFGLTK 161
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 35.0 bits (79), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 17/32 (53%), Positives = 21/32 (65%), Gaps = 4/32 (12%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
++HRDLA RN LV + VKIGDFGL +
Sbjct: 138 YIHRDLATRNILVENENR----VKIGDFGLTK 165
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 35.0 bits (79), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 17/32 (53%), Positives = 21/32 (65%), Gaps = 4/32 (12%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
++HRDLA RN LV + VKIGDFGL +
Sbjct: 135 YIHRDLATRNILVENENR----VKIGDFGLTK 162
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 35.0 bits (79), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 17/32 (53%), Positives = 21/32 (65%), Gaps = 4/32 (12%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
++HRDLA RN LV + VKIGDFGL +
Sbjct: 153 YIHRDLATRNILVENENR----VKIGDFGLTK 180
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 34.7 bits (78), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 17/32 (53%), Positives = 21/32 (65%), Gaps = 4/32 (12%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
++HRDLA RN LV + VKIGDFGL +
Sbjct: 140 YIHRDLATRNILVENENR----VKIGDFGLTK 167
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 34.7 bits (78), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 17/32 (53%), Positives = 21/32 (65%), Gaps = 4/32 (12%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
++HRDLA RN LV + VKIGDFGL +
Sbjct: 135 YIHRDLATRNILVENENR----VKIGDFGLTK 162
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 34.7 bits (78), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 17/32 (53%), Positives = 21/32 (65%), Gaps = 4/32 (12%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
++HRDLA RN LV + VKIGDFGL +
Sbjct: 141 YIHRDLATRNILVENENR----VKIGDFGLTK 168
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 34.7 bits (78), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 17/32 (53%), Positives = 21/32 (65%), Gaps = 4/32 (12%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
++HRDLA RN LV + VKIGDFGL +
Sbjct: 142 YIHRDLATRNILVENENR----VKIGDFGLTK 169
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 34.7 bits (78), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 17/32 (53%), Positives = 21/32 (65%), Gaps = 4/32 (12%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
++HRDLA RN LV + VKIGDFGL +
Sbjct: 139 YIHRDLATRNILVENENR----VKIGDFGLTK 166
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 34.7 bits (78), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 17/32 (53%), Positives = 21/32 (65%), Gaps = 4/32 (12%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
++HRDLA RN LV + VKIGDFGL +
Sbjct: 138 YIHRDLATRNILVENENR----VKIGDFGLTK 165
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 34.7 bits (78), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 17/32 (53%), Positives = 21/32 (65%), Gaps = 4/32 (12%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
++HRDLA RN LV + VKIGDFGL +
Sbjct: 138 YIHRDLATRNILVENENR----VKIGDFGLTK 165
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 34.3 bits (77), Expect = 0.019, Method: Composition-based stats.
Identities = 17/34 (50%), Positives = 22/34 (64%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
M VHRDLAARN L++ + K+ DFGL+R
Sbjct: 166 MGAVHRDLAARNILIN----SNLVCKVSDFGLSR 195
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 33.9 bits (76), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 17/34 (50%), Positives = 22/34 (64%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+ +VHRDLAARN LV + K+ DFGL+R
Sbjct: 170 LGYVHRDLAARNVLVDS----NLVCKVSDFGLSR 199
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 33.9 bits (76), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 17/34 (50%), Positives = 22/34 (64%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+ +VHRDLAARN LV + K+ DFGL+R
Sbjct: 170 LGYVHRDLAARNVLVDS----NLVCKVSDFGLSR 199
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 33.9 bits (76), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 20/45 (44%), Positives = 25/45 (55%), Gaps = 4/45 (8%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
+++HRDL A N LVS KI DFGLAR I + +EG
Sbjct: 129 NYIHRDLRAANILVS----DTLSCKIADFGLARLIEDAEXTAREG 169
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 33.5 bits (75), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 17/34 (50%), Positives = 22/34 (64%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
M VHRDLAARN LV+ + K+ DFG++R
Sbjct: 150 MSAVHRDLAARNILVNS----NLVCKVSDFGMSR 179
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 33.5 bits (75), Expect = 0.030, Method: Composition-based stats.
Identities = 17/33 (51%), Positives = 21/33 (63%), Gaps = 4/33 (12%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+++HRDL A N LVS + KI DFGLAR
Sbjct: 298 NYIHRDLRAANILVSA----SLVCKIADFGLAR 326
>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex
With A Staurosporine Analogue
Length = 290
Score = 33.5 bits (75), Expect = 0.034, Method: Compositional matrix adjust.
Identities = 19/31 (61%), Positives = 20/31 (64%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
VHRDLAARN LV VKI DFGLA+
Sbjct: 133 VHRDLAARNILVE----SEAHVKIADFGLAK 159
>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|E Chain E, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|F Chain F, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
Length = 303
Score = 33.1 bits (74), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 21/58 (36%), Positives = 33/58 (56%), Gaps = 5/58 (8%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRN-DYYKKEGEGLLPVSFAITVVI 60
+HR+L N + + R VKIGDFGLA++++R+ D K + + L S +T I
Sbjct: 138 IHRNLKPXNIFID----ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|B Chain B, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|C Chain C, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|D Chain D, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|E Chain E, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|F Chain F, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
Length = 285
Score = 33.1 bits (74), Expect = 0.038, Method: Compositional matrix adjust.
Identities = 23/76 (30%), Positives = 37/76 (48%), Gaps = 7/76 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVIE 61
H VH+DL N L P + +KI DFGLA +++++D + G A+ + E
Sbjct: 144 HVVHKDLKPENILFQDTSP-HSPIKIIDFGLA-ELFKSDEHSTNAAGT-----ALYMAPE 196
Query: 62 SKNRSVPFRPELCVYG 77
R V F+ ++ G
Sbjct: 197 VFKRDVTFKCDIWSAG 212
>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii,
25.M01780 Or Tgme49_007820
Length = 458
Score = 32.7 bits (73), Expect = 0.053, Method: Compositional matrix adjust.
Identities = 22/52 (42%), Positives = 28/52 (53%), Gaps = 12/52 (23%)
Query: 4 VHRDLAARNCLVS--CLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVS 53
+HRDL NCLV+ C VK+ DFGLAR + Y + G LP+S
Sbjct: 178 LHRDLKPANCLVNQDC------SVKVCDFGLARTV----DYPENGNSQLPIS 219
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 32.3 bits (72), Expect = 0.069, Method: Compositional matrix adjust.
Identities = 16/34 (47%), Positives = 22/34 (64%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
M+ +HRDL + NCLV + + V + DFGLAR
Sbjct: 127 MNIIHRDLNSHNCLVR----ENKNVVVADFGLAR 156
>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
pdb|2I6L|B Chain B, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
Length = 320
Score = 32.0 bits (71), Expect = 0.092, Method: Compositional matrix adjust.
Identities = 20/50 (40%), Positives = 30/50 (60%), Gaps = 8/50 (16%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG---EGLL 50
+HRDL N ++ D ++KIGDFGLAR + + +Y +G EGL+
Sbjct: 142 LHRDLKPANLFINTED---LVLKIGDFGLARIM--DPHYSHKGHLSEGLV 186
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 31.2 bits (69), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 16/33 (48%), Positives = 20/33 (60%), Gaps = 4/33 (12%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
H +HRD+ + N L LD + KI DFGLAR
Sbjct: 153 HHIHRDIKSANIL---LDEAF-TAKISDFGLAR 181
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 31.2 bits (69), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 16/33 (48%), Positives = 20/33 (60%), Gaps = 4/33 (12%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
H +HRD+ + N L LD + KI DFGLAR
Sbjct: 153 HHIHRDIKSANIL---LDEAF-TAKISDFGLAR 181
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 31.2 bits (69), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 15/31 (48%), Positives = 21/31 (67%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ K +K+GDFGLAR
Sbjct: 130 LHRDLKPQNLLIN----KRGQLKLGDFGLAR 156
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 30.8 bits (68), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 16/33 (48%), Positives = 20/33 (60%), Gaps = 4/33 (12%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
H +HRD+ + N L LD + KI DFGLAR
Sbjct: 147 HHIHRDIKSANIL---LDEAF-TAKISDFGLAR 175
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 30.8 bits (68), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 16/33 (48%), Positives = 20/33 (60%), Gaps = 4/33 (12%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
H +HRD+ + N L LD + KI DFGLAR
Sbjct: 144 HHIHRDIKSANIL---LDEAF-TAKISDFGLAR 172
>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662
Length = 279
Score = 30.8 bits (68), Expect = 0.22, Method: Compositional matrix adjust.
Identities = 19/42 (45%), Positives = 26/42 (61%), Gaps = 4/42 (9%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKE 45
+HRDL N LD K + VK+GDFGLAR + ++ + KE
Sbjct: 138 LHRDLKPANVF---LDGK-QNVKLGDFGLARILNHDEDFAKE 175
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 30.4 bits (67), Expect = 0.24, Method: Compositional matrix adjust.
Identities = 16/43 (37%), Positives = 26/43 (60%), Gaps = 5/43 (11%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYR-NDYYKKE 45
+HRD+ N L++ K+ ++K+ DFG AR + +DYY E
Sbjct: 124 IHRDVKPENILIT----KHSVIKLCDFGFARLLTGPSDYYDDE 162
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 30.4 bits (67), Expect = 0.26, Method: Compositional matrix adjust.
Identities = 14/36 (38%), Positives = 22/36 (61%), Gaps = 3/36 (8%)
Query: 5 HRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND 40
HRD+ +N L LDP ++K+ DFG A+ + R +
Sbjct: 145 HRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGE 177
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 30.4 bits (67), Expect = 0.26, Method: Compositional matrix adjust.
Identities = 14/36 (38%), Positives = 22/36 (61%), Gaps = 3/36 (8%)
Query: 5 HRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND 40
HRD+ +N L LDP ++K+ DFG A+ + R +
Sbjct: 145 HRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGE 177
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 30.4 bits (67), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 14/36 (38%), Positives = 22/36 (61%), Gaps = 3/36 (8%)
Query: 5 HRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND 40
HRD+ +N L LDP ++K+ DFG A+ + R +
Sbjct: 145 HRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGE 177
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 30.4 bits (67), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 14/36 (38%), Positives = 22/36 (61%), Gaps = 3/36 (8%)
Query: 5 HRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND 40
HRD+ +N L LDP ++K+ DFG A+ + R +
Sbjct: 153 HRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGE 185
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 30.4 bits (67), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 14/36 (38%), Positives = 22/36 (61%), Gaps = 3/36 (8%)
Query: 5 HRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND 40
HRD+ +N L LDP ++K+ DFG A+ + R +
Sbjct: 145 HRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGE 177
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 30.4 bits (67), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 14/36 (38%), Positives = 22/36 (61%), Gaps = 3/36 (8%)
Query: 5 HRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND 40
HRD+ +N L LDP ++K+ DFG A+ + R +
Sbjct: 157 HRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGE 189
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 30.4 bits (67), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 14/36 (38%), Positives = 22/36 (61%), Gaps = 3/36 (8%)
Query: 5 HRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND 40
HRD+ +N L LDP ++K+ DFG A+ + R +
Sbjct: 145 HRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGE 177
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 30.4 bits (67), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 14/36 (38%), Positives = 22/36 (61%), Gaps = 3/36 (8%)
Query: 5 HRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND 40
HRD+ +N L LDP ++K+ DFG A+ + R +
Sbjct: 146 HRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGE 178
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 30.4 bits (67), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 14/36 (38%), Positives = 22/36 (61%), Gaps = 3/36 (8%)
Query: 5 HRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND 40
HRD+ +N L LDP ++K+ DFG A+ + R +
Sbjct: 164 HRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGE 196
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 30.4 bits (67), Expect = 0.27, Method: Compositional matrix adjust.
Identities = 14/36 (38%), Positives = 22/36 (61%), Gaps = 3/36 (8%)
Query: 5 HRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND 40
HRD+ +N L LDP ++K+ DFG A+ + R +
Sbjct: 145 HRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGE 177
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 30.4 bits (67), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 14/36 (38%), Positives = 22/36 (61%), Gaps = 3/36 (8%)
Query: 5 HRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND 40
HRD+ +N L LDP ++K+ DFG A+ + R +
Sbjct: 157 HRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGE 189
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 30.4 bits (67), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 14/36 (38%), Positives = 22/36 (61%), Gaps = 3/36 (8%)
Query: 5 HRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND 40
HRD+ +N L LDP ++K+ DFG A+ + R +
Sbjct: 149 HRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGE 181
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 30.4 bits (67), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 14/36 (38%), Positives = 22/36 (61%), Gaps = 3/36 (8%)
Query: 5 HRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND 40
HRD+ +N L LDP ++K+ DFG A+ + R +
Sbjct: 145 HRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGE 177
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 30.4 bits (67), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 14/36 (38%), Positives = 22/36 (61%), Gaps = 3/36 (8%)
Query: 5 HRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND 40
HRD+ +N L LDP ++K+ DFG A+ + R +
Sbjct: 158 HRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGE 190
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 30.0 bits (66), Expect = 0.31, Method: Composition-based stats.
Identities = 14/36 (38%), Positives = 22/36 (61%), Gaps = 3/36 (8%)
Query: 5 HRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND 40
HRD+ +N L LDP ++K+ DFG A+ + R +
Sbjct: 150 HRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGE 182
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 30.0 bits (66), Expect = 0.31, Method: Composition-based stats.
Identities = 14/36 (38%), Positives = 22/36 (61%), Gaps = 3/36 (8%)
Query: 5 HRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND 40
HRD+ +N L LDP ++K+ DFG A+ + R +
Sbjct: 173 HRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGE 205
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 30.0 bits (66), Expect = 0.31, Method: Composition-based stats.
Identities = 14/36 (38%), Positives = 22/36 (61%), Gaps = 3/36 (8%)
Query: 5 HRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND 40
HRD+ +N L LDP ++K+ DFG A+ + R +
Sbjct: 179 HRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGE 211
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 30.0 bits (66), Expect = 0.31, Method: Composition-based stats.
Identities = 14/36 (38%), Positives = 22/36 (61%), Gaps = 3/36 (8%)
Query: 5 HRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND 40
HRD+ +N L LDP ++K+ DFG A+ + R +
Sbjct: 224 HRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGE 256
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 30.0 bits (66), Expect = 0.31, Method: Composition-based stats.
Identities = 15/34 (44%), Positives = 21/34 (61%), Gaps = 2/34 (5%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
M+ +H DL N L C++ + +KI DFGLAR
Sbjct: 206 MYILHLDLKPENIL--CVNRDAKQIKIIDFGLAR 237
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 30.0 bits (66), Expect = 0.33, Method: Composition-based stats.
Identities = 14/36 (38%), Positives = 22/36 (61%), Gaps = 3/36 (8%)
Query: 5 HRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND 40
HRD+ +N L LDP ++K+ DFG A+ + R +
Sbjct: 183 HRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGE 215
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 30.0 bits (66), Expect = 0.33, Method: Composition-based stats.
Identities = 14/36 (38%), Positives = 22/36 (61%), Gaps = 3/36 (8%)
Query: 5 HRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND 40
HRD+ +N L LDP ++K+ DFG A+ + R +
Sbjct: 179 HRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGE 211
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 30.0 bits (66), Expect = 0.35, Method: Composition-based stats.
Identities = 14/36 (38%), Positives = 22/36 (61%), Gaps = 3/36 (8%)
Query: 5 HRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND 40
HRD+ +N L LDP ++K+ DFG A+ + R +
Sbjct: 181 HRDIKPQNLL---LDPDTAVLKLCDFGSAKQLVRGE 213
>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
pdb|2JC6|C Chain C, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
Length = 334
Score = 30.0 bits (66), Expect = 0.37, Method: Compositional matrix adjust.
Identities = 15/34 (44%), Positives = 20/34 (58%), Gaps = 1/34 (2%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
M VHRDL N L D + +I+ I DFGL++
Sbjct: 139 MGIVHRDLKPENLLYYSQDEESKIM-ISDFGLSK 171
>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FG9|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FGB|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I Apo Form
Length = 320
Score = 29.6 bits (65), Expect = 0.40, Method: Compositional matrix adjust.
Identities = 15/31 (48%), Positives = 19/31 (61%), Gaps = 1/31 (3%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
VHRDL N L LD +I+ I DFGL++
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIM-ISDFGLSK 167
>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat
Length = 332
Score = 29.6 bits (65), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 15/31 (48%), Positives = 19/31 (61%), Gaps = 1/31 (3%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
VHRDL N L LD +I+ I DFGL++
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIM-ISDFGLSK 167
>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
pdb|4FG8|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
Length = 315
Score = 29.6 bits (65), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 15/31 (48%), Positives = 19/31 (61%), Gaps = 1/31 (3%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
VHRDL N L LD +I+ I DFGL++
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIM-ISDFGLSK 167
>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147
pdb|3NIE|B Chain B, Crystal Structure Of Pf11_0147
Length = 429
Score = 29.6 bits (65), Expect = 0.43, Method: Compositional matrix adjust.
Identities = 18/35 (51%), Positives = 21/35 (60%), Gaps = 8/35 (22%)
Query: 4 VHRDLAARNCLVS--CLDPKYRIVKIGDFGLARDI 36
+HRDL NCL++ C VKI DFGLAR I
Sbjct: 153 IHRDLKPANCLLNQDC------SVKICDFGLARTI 181
>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|C Chain C, Crystal Structure Of Cdk4CYCLIN D3
Length = 308
Score = 29.6 bits (65), Expect = 0.43, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 18/31 (58%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
VHRDL N LV+ VK+ DFGLAR
Sbjct: 142 VHRDLKPENILVTSGG----TVKLADFGLAR 168
>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9Z|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 29.6 bits (65), Expect = 0.44, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 18/31 (58%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
VHRDL N LV+ VK+ DFGLAR
Sbjct: 134 VHRDLKPENILVTSGG----TVKLADFGLAR 160
>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 29.6 bits (65), Expect = 0.44, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 18/31 (58%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
VHRDL N LV+ VK+ DFGLAR
Sbjct: 134 VHRDLKPENILVTSGG----TVKLADFGLAR 160
>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-293 In Complex With Atp
Length = 293
Score = 29.6 bits (65), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 15/31 (48%), Positives = 19/31 (61%), Gaps = 1/31 (3%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
VHRDL N L LD +I+ I DFGL++
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIM-ISDFGLSK 167
>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 29.6 bits (65), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 16/31 (51%), Positives = 18/31 (58%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
VHRDL N LV+ VK+ DFGLAR
Sbjct: 134 VHRDLKPENILVTSGG----TVKLADFGLAR 160
>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|A Chain A, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
Length = 373
Score = 29.3 bits (64), Expect = 0.51, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 21/31 (67%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRD+ A N L++ + ++K+ DFGLAR
Sbjct: 147 LHRDMKAANVLIT----RDGVLKLADFGLAR 173
>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
pdb|3N9X|B Chain B, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
Length = 432
Score = 29.3 bits (64), Expect = 0.55, Method: Compositional matrix adjust.
Identities = 17/35 (48%), Positives = 21/35 (60%), Gaps = 8/35 (22%)
Query: 4 VHRDLAARNCLVS--CLDPKYRIVKIGDFGLARDI 36
+HRDL NCL++ C VK+ DFGLAR I
Sbjct: 151 IHRDLKPANCLLNQDC------SVKVCDFGLARTI 179
>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|3NUX|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|4AUA|A Chain A, Liganded X-ray Crystal Structure Of Cyclin Dependent
Kinase 6 (cdk6)
pdb|4EZ5|A Chain A, Cdk6 (monomeric) In Complex With Inhibitor
Length = 307
Score = 29.3 bits (64), Expect = 0.55, Method: Compositional matrix adjust.
Identities = 15/31 (48%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
VHRDL +N LV+ +K+ DFGLAR
Sbjct: 142 VHRDLKPQNILVTSSGQ----IKLADFGLAR 168
>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI8|C Chain C, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI7|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structure Of The Cdk6-P16ink4a Tumor Suppressor
Complex
pdb|1BLX|A Chain A, P19ink4dCDK6 COMPLEX
pdb|1G3N|A Chain A, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
pdb|1G3N|E Chain E, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
Length = 326
Score = 29.3 bits (64), Expect = 0.56, Method: Compositional matrix adjust.
Identities = 15/31 (48%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
VHRDL +N LV+ +K+ DFGLAR
Sbjct: 142 VHRDLKPQNILVTSSGQ----IKLADFGLAR 168
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 29.3 bits (64), Expect = 0.57, Method: Compositional matrix adjust.
Identities = 15/35 (42%), Positives = 20/35 (57%), Gaps = 4/35 (11%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYR 38
+HRDL + N + + VKIGDFGLA + R
Sbjct: 142 IHRDLKSNNIFLH----EDNTVKIGDFGLATEKSR 172
>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 351
Score = 29.3 bits (64), Expect = 0.57, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 21/31 (67%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRD+ A N L++ + ++K+ DFGLAR
Sbjct: 146 LHRDMKAANVLIT----RDGVLKLADFGLAR 172
>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|A Chain A, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|A Chain A, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNH|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|A Chain A, Structure Of Cdk9CYCLIN T F241L
pdb|4BCH|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 29.3 bits (64), Expect = 0.57, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 21/31 (67%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRD+ A N L++ + ++K+ DFGLAR
Sbjct: 147 LHRDMKAANVLIT----RDGVLKLADFGLAR 173
>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 29.3 bits (64), Expect = 0.58, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 21/31 (67%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRD+ A N L++ + ++K+ DFGLAR
Sbjct: 147 LHRDMKAANVLIT----RDGVLKLADFGLAR 173
>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC
Length = 405
Score = 29.3 bits (64), Expect = 0.61, Method: Composition-based stats.
Identities = 15/31 (48%), Positives = 17/31 (54%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL N LV P+ VKI D G AR
Sbjct: 150 LHRDLKPANILVMGEGPERGRVKIADMGFAR 180
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 29.3 bits (64), Expect = 0.61, Method: Compositional matrix adjust.
Identities = 15/35 (42%), Positives = 20/35 (57%), Gaps = 4/35 (11%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYR 38
+HRDL + N + + VKIGDFGLA + R
Sbjct: 142 IHRDLKSNNIFLH----EDNTVKIGDFGLATEKSR 172
>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
Cyclin
pdb|1XO2|B Chain B, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
Complex With A Flavonol Inhibitor, Fisetin
pdb|2EUF|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
Inhibitor Pd0332991
pdb|2F2C|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
Aminopurvalanol
Length = 308
Score = 29.3 bits (64), Expect = 0.62, Method: Compositional matrix adjust.
Identities = 15/31 (48%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
VHRDL +N LV+ +K+ DFGLAR
Sbjct: 142 VHRDLKPQNILVTSSGQ----IKLADFGLAR 168
>pdb|1VKH|A Chain A, Crystal Structure Of A Putative Serine Hydrolase (Ydr428c)
From Saccharomyces Cerevisiae At 1.85 A Resolution
pdb|1VKH|B Chain B, Crystal Structure Of A Putative Serine Hydrolase (Ydr428c)
From Saccharomyces Cerevisiae At 1.85 A Resolution
Length = 273
Score = 28.9 bits (63), Expect = 0.67, Method: Compositional matrix adjust.
Identities = 17/47 (36%), Positives = 24/47 (51%), Gaps = 10/47 (21%)
Query: 2 HFVHR------DLAARNCLVSCLDPKYRI---VKIGDFGLARDIYRN 39
H VH L NCL+SCL Y++ + + D GL D+Y+N
Sbjct: 216 HLVHSYSDELLTLRQTNCLISCLQ-DYQLSFKLYLDDLGLHNDVYKN 261
>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|B Chain B, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|C Chain C, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|D Chain D, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
Length = 432
Score = 28.9 bits (63), Expect = 0.79, Method: Composition-based stats.
Identities = 16/49 (32%), Positives = 27/49 (55%), Gaps = 3/49 (6%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRI-VKIGDFGLARDIY--RNDYYKKEG 46
++ VHRDL N L+S + +I I DFGL + + R+ + ++ G
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor
Length = 398
Score = 28.5 bits (62), Expect = 0.91, Method: Composition-based stats.
Identities = 15/33 (45%), Positives = 21/33 (63%), Gaps = 4/33 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
+HRDL N LV+ + +KIGDFG+AR +
Sbjct: 180 IHRDLKPSNLLVN----ENCELKIGDFGMARGL 208
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 28.5 bits (62), Expect = 0.92, Method: Compositional matrix adjust.
Identities = 19/48 (39%), Positives = 26/48 (54%), Gaps = 5/48 (10%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLL 50
+HRDL N + +D K VKIGDFGL + +ND + +G L
Sbjct: 157 LIHRDLKPSNIFL--VDTKQ--VKIGDFGLVTSL-KNDGKRTRSKGTL 199
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 28.5 bits (62), Expect = 0.99, Method: Compositional matrix adjust.
Identities = 15/35 (42%), Positives = 20/35 (57%), Gaps = 4/35 (11%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYR 38
+HRDL + N + + VKIGDFGLA + R
Sbjct: 126 IHRDLKSNNIFLH----EDLTVKIGDFGLATEKSR 156
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 28.5 bits (62), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 13/33 (39%), Positives = 19/33 (57%), Gaps = 1/33 (3%)
Query: 4 VHRDLAARNCLVSCLDPKYRI-VKIGDFGLARD 35
VHRDL + N + LD + K+ DFGL++
Sbjct: 146 VHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ 178
>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound
pdb|2WQO|A Chain A, Structure Of Nek2 Bound To The Aminopyridine Cct241950
pdb|2XK3|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 35
pdb|2XK4|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 17
pdb|2XK6|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 36
pdb|2XK7|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 23
pdb|2XK8|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 15
pdb|2XKC|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 14
pdb|2XKD|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 12
pdb|2XKF|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 2
pdb|2XKE|A Chain A, Structure Of Nek2 Bound To Aminipyrazine Compound 5
pdb|2XNM|A Chain A, Structure Of Nek2 Bound To Cct
pdb|2XNN|A Chain A, Structure Of Nek2 Bound To Cct242430
pdb|2XNO|A Chain A, Structure Of Nek2 Bound To Cct243779
pdb|2XNP|A Chain A, Structure Of Nek2 Bound To Cct244858
pdb|4AFE|A Chain A, Nek2 Bound To Hybrid Compound 21
Length = 279
Score = 28.5 bits (62), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 17/31 (54%), Positives = 20/31 (64%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL N LD K + VK+GDFGLAR
Sbjct: 138 LHRDLKPANVF---LDGK-QNVKLGDFGLAR 164
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 28.5 bits (62), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 17/52 (32%), Positives = 26/52 (50%), Gaps = 4/52 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
VHR+LAARN L+ V++ DFG+A + +D E P+ +
Sbjct: 136 MVHRNLAARNVLLKSPSQ----VQVADFGVADLLPPDDKQLLYSEAKTPIKW 183
>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC7|D Chain D, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC8|A Chain A, Crystal Structure Of The Apo Erk5 Kinase Domain
pdb|4IC8|B Chain B, Crystal Structure Of The Apo Erk5 Kinase Domain
Length = 442
Score = 28.5 bits (62), Expect = 1.0, Method: Composition-based stats.
Identities = 15/33 (45%), Positives = 21/33 (63%), Gaps = 4/33 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
+HRDL N LV+ + +KIGDFG+AR +
Sbjct: 181 IHRDLKPSNLLVN----ENCELKIGDFGMARGL 209
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 28.5 bits (62), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 13/34 (38%), Positives = 20/34 (58%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
M VHRD+ +N L+ + +KI DFG+A+
Sbjct: 130 MRIVHRDIKPQNILIDS----NKTLKIFDFGIAK 159
>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand
pdb|2W5B|A Chain A, Human Nek2 Kinase Atpgammas-bound
pdb|2W5H|A Chain A, Human Nek2 Kinase Apo
Length = 279
Score = 28.5 bits (62), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 17/31 (54%), Positives = 20/31 (64%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL N LD K + VK+GDFGLAR
Sbjct: 138 LHRDLKPANVF---LDGK-QNVKLGDFGLAR 164
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 28.1 bits (61), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 14/30 (46%), Positives = 18/30 (60%), Gaps = 4/30 (13%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLA 33
+HRDL + N + + VKIGDFGLA
Sbjct: 130 IHRDLKSNNIFLH----EDNTVKIGDFGLA 155
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 28.1 bits (61), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 15/35 (42%), Positives = 20/35 (57%), Gaps = 4/35 (11%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYR 38
+HRDL + N + + VKIGDFGLA + R
Sbjct: 154 IHRDLKSNNIFLH----EDLTVKIGDFGLATEKSR 184
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 28.1 bits (61), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 15/35 (42%), Positives = 20/35 (57%), Gaps = 4/35 (11%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYR 38
+HRDL + N + + VKIGDFGLA + R
Sbjct: 146 IHRDLKSNNIFLH----EDLTVKIGDFGLATEKSR 176
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 28.1 bits (61), Expect = 1.2, Method: Composition-based stats.
Identities = 15/30 (50%), Positives = 20/30 (66%), Gaps = 4/30 (13%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLA 33
VHR+LAARN L+ P V++ DFG+A
Sbjct: 155 VHRNLAARNVLLK--SPSQ--VQVADFGVA 180
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 28.1 bits (61), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 132 LHRDLKPQNLLINTEG----AIKLADFGLAR 158
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 28.1 bits (61), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 20/31 (64%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ + +KI DFGLAR
Sbjct: 122 LHRDLKPQNLLIN----REGELKIADFGLAR 148
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 28.1 bits (61), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 125 LHRDLKPQNLLINTEGA----IKLADFGLAR 151
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 28.1 bits (61), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 20/31 (64%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ + +KI DFGLAR
Sbjct: 122 LHRDLKPQNLLIN----REGELKIADFGLAR 148
>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
pdb|3F69|B Chain B, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
Length = 311
Score = 28.1 bits (61), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 14/34 (41%), Positives = 20/34 (58%), Gaps = 4/34 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
+HRD+ N L+S + VK+ DFG+AR I
Sbjct: 137 IIHRDVKPANILISATN----AVKVVDFGIARAI 166
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 28.1 bits (61), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 14/31 (45%), Positives = 20/31 (64%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ + +KI DFGLAR
Sbjct: 122 LHRDLKPQNLLIN----REGELKIADFGLAR 148
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 28.1 bits (61), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 132 LHRDLKPQNLLINTEG----AIKLADFGLAR 158
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 28.1 bits (61), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 125 LHRDLKPQNLLINTEGA----IKLADFGLAR 151
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 28.1 bits (61), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 125 LHRDLKPQNLLINTEGA----IKLADFGLAR 151
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 28.1 bits (61), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 128 LHRDLKPQNLLINTEG----AIKLADFGLAR 154
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 28.1 bits (61), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 124 LHRDLKPQNLLINTEGA----IKLADFGLAR 150
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 28.1 bits (61), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 124 LHRDLKPQNLLINTEGA----IKLADFGLAR 150
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 28.1 bits (61), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 129 LHRDLKPQNLLINTEG----AIKLADFGLAR 155
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 128 LHRDLKPQNLLINTEG----AIKLADFGLAR 154
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 125 LHRDLKPQNLLINTEGA----IKLADFGLAR 151
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 127 LHRDLKPQNLLINTEG----AIKLADFGLAR 153
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 125 LHRDLKPQNLLINTEGA----IKLADFGLAR 151
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 124 LHRDLKPQNLLINTEGA----IKLADFGLAR 150
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 124 LHRDLKPQNLLINTEGA----IKLADFGLAR 150
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 124 LHRDLKPQNLLINTEGA----IKLADFGLAR 150
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 124 LHRDLKPQNLLINTEGA----IKLADFGLAR 150
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 125 LHRDLKPQNLLINTEGA----IKLADFGLAR 151
>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain
Length = 332
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 13/30 (43%), Positives = 17/30 (56%), Gaps = 4/30 (13%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGL 32
+HRDL N + D +VK+GDFGL
Sbjct: 185 LMHRDLKPSNIFFTMDD----VVKVGDFGL 210
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 126 LHRDLKPQNLLINTEGA----IKLADFGLAR 152
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 125 LHRDLKPQNLLINTEGA----IKLADFGLAR 151
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 128 LHRDLKPQNLLINTEG----AIKLADFGLAR 154
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 127 LHRDLKPQNLLINTEG----AIKLADFGLAR 153
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 126 LHRDLKPQNLLINTEGA----IKLADFGLAR 152
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 126 LHRDLKPQNLLINTEGA----IKLADFGLAR 152
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 125 LHRDLKPQNLLINTEGA----IKLADFGLAR 151
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 125 LHRDLKPQNLLINTEGA----IKLADFGLAR 151
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 128 LHRDLKPQNLLINTEG----AIKLADFGLAR 154
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 127 LHRDLKPQNLLINTEGA----IKLADFGLAR 153
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 27.7 bits (60), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 129 LHRDLKPQNLLINTEG----AIKLADFGLAR 155
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 27.7 bits (60), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 128 LHRDLKPQNLLINTEG----AIKLADFGLAR 154
>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4APC|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4B9D|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor.
pdb|4B9D|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor
Length = 350
Score = 27.7 bits (60), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 12/31 (38%), Positives = 21/31 (67%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRD+ ++N ++ K V++GDFG+AR
Sbjct: 147 LHRDIKSQNIFLT----KDGTVQLGDFGIAR 173
>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant
Length = 311
Score = 27.7 bits (60), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 13/34 (38%), Positives = 20/34 (58%), Gaps = 4/34 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
+HRD+ N ++S + VK+ DFG+AR I
Sbjct: 137 IIHRDVKPANIMISATN----AVKVMDFGIARAI 166
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 27.7 bits (60), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 14/33 (42%), Positives = 20/33 (60%), Gaps = 4/33 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
+HRD+ N LVS + +VK+ DFG AR +
Sbjct: 146 IHRDIKPENILVS----QSGVVKLCDFGFARTL 174
>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb.
pdb|1MRU|B Chain B, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb
Length = 311
Score = 27.7 bits (60), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 13/34 (38%), Positives = 20/34 (58%), Gaps = 4/34 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
+HRD+ N ++S + VK+ DFG+AR I
Sbjct: 137 IIHRDVKPANIMISATN----AVKVMDFGIARAI 166
>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|B Chain B, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|C Chain C, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|D Chain D, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORK|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 2)
pdb|3ORL|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 3)
pdb|3ORO|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 4)
pdb|3ORP|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 5)
pdb|3ORT|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 6)
Length = 311
Score = 27.7 bits (60), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 13/34 (38%), Positives = 20/34 (58%), Gaps = 4/34 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
+HRD+ N ++S + VK+ DFG+AR I
Sbjct: 137 IIHRDVKPANIMISATN----AVKVMDFGIARAI 166
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 27.7 bits (60), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 14/30 (46%), Positives = 18/30 (60%), Gaps = 4/30 (13%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLA 33
+HRDL + N + + VKIGDFGLA
Sbjct: 126 IHRDLKSNNIFLH----EDLTVKIGDFGLA 151
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 27.7 bits (60), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 14/30 (46%), Positives = 18/30 (60%), Gaps = 4/30 (13%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLA 33
+HRDL + N + + VKIGDFGLA
Sbjct: 131 IHRDLKSNNIFLH----EDLTVKIGDFGLA 156
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 27.7 bits (60), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 14/30 (46%), Positives = 18/30 (60%), Gaps = 4/30 (13%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLA 33
+HRDL + N + + VKIGDFGLA
Sbjct: 131 IHRDLKSNNIFLH----EDLTVKIGDFGLA 156
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 27.3 bits (59), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 14/30 (46%), Positives = 18/30 (60%), Gaps = 4/30 (13%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLA 33
+HRDL + N + + VKIGDFGLA
Sbjct: 126 IHRDLKSNNIFLH----EDLTVKIGDFGLA 151
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 27.3 bits (59), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 18/31 (58%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL N L++ +K+ DFGLAR
Sbjct: 127 LHRDLKPENLLINTEG----AIKLADFGLAR 153
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 27.3 bits (59), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 14/30 (46%), Positives = 18/30 (60%), Gaps = 4/30 (13%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLA 33
+HRDL + N + + VKIGDFGLA
Sbjct: 128 IHRDLKSNNIFLH----EDLTVKIGDFGLA 153
>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb
Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP
Length = 311
Score = 27.3 bits (59), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 13/34 (38%), Positives = 20/34 (58%), Gaps = 4/34 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
+HRD+ N ++S + VK+ DFG+AR I
Sbjct: 137 IIHRDVKPANIMISATN----AVKVMDFGIARAI 166
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 27.3 bits (59), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 18/31 (58%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL N L++ +K+ DFGLAR
Sbjct: 128 LHRDLKPENLLINTEG----AIKLADFGLAR 154
>pdb|2PJD|A Chain A, Crystal Structure Of 16s Rrna Methyltransferase Rsmc
Length = 343
Score = 27.3 bits (59), Expect = 2.0, Method: Composition-based stats.
Identities = 15/42 (35%), Positives = 22/42 (52%)
Query: 49 LLPVSFAITVVIESKNRSVPFRPELCVYGPLADIDSIKKVGI 90
LLPV I VV E+++ L Y PL +DS ++ G+
Sbjct: 101 LLPVGTDIFVVGENRSGVRSAEQXLADYAPLNKVDSARRCGL 142
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 27.3 bits (59), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 18/31 (58%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL N L++ +K+ DFGLAR
Sbjct: 126 LHRDLKPENLLINTEGA----IKLADFGLAR 152
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 27.3 bits (59), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 18/31 (58%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL N L++ +K+ DFGLAR
Sbjct: 126 LHRDLKPENLLINTEGA----IKLADFGLAR 152
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 27.3 bits (59), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 13/31 (41%), Positives = 18/31 (58%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL N L++ +K+ DFGLAR
Sbjct: 125 LHRDLKPENLLINTEGA----IKLADFGLAR 151
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 27.3 bits (59), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 14/30 (46%), Positives = 18/30 (60%), Gaps = 4/30 (13%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLA 33
+HRDL + N + + VKIGDFGLA
Sbjct: 153 IHRDLKSNNIFLH----EDLTVKIGDFGLA 178
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 27.3 bits (59), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 14/30 (46%), Positives = 18/30 (60%), Gaps = 4/30 (13%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLA 33
+HRDL + N + + VKIGDFGLA
Sbjct: 154 IHRDLKSNNIFLH----EDLTVKIGDFGLA 179
>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium
Tuberculosis
pdb|2FUM|A Chain A, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|B Chain B, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|C Chain C, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|D Chain D, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
Length = 299
Score = 27.3 bits (59), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 13/34 (38%), Positives = 20/34 (58%), Gaps = 4/34 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
+HRD+ N ++S + VK+ DFG+AR I
Sbjct: 154 IIHRDVKPANIMISATN----AVKVMDFGIARAI 183
>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.28 A Resolution
pdb|4G34|A Chain A, Crystal Structure Of Gsk6924 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.70 A Resolution
Length = 299
Score = 27.3 bits (59), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 13/30 (43%), Positives = 17/30 (56%), Gaps = 4/30 (13%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGL 32
+HRDL N + D +VK+GDFGL
Sbjct: 139 LMHRDLKPSNIFFTMDD----VVKVGDFGL 164
>pdb|3AV0|A Chain A, Crystal Structure Of Mre11-Rad50 Bound To Atp S
Length = 386
Score = 27.3 bits (59), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 14/27 (51%), Positives = 17/27 (62%), Gaps = 2/27 (7%)
Query: 31 GLARDIYRNDY--YKKEGEGLLPVSFA 55
G IYRN+Y YKKEG+G V F+
Sbjct: 224 GSTEIIYRNEYEDYKKEGKGFYLVDFS 250
>pdb|3AUZ|A Chain A, Crystal Structure Of Mre11 With Manganese
Length = 333
Score = 27.3 bits (59), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 14/27 (51%), Positives = 17/27 (62%), Gaps = 2/27 (7%)
Query: 31 GLARDIYRNDY--YKKEGEGLLPVSFA 55
G IYRN+Y YKKEG+G V F+
Sbjct: 224 GSTEIIYRNEYEDYKKEGKGFYLVDFS 250
>pdb|3BGW|A Chain A, The Structure Of A Dnab-like Replicative Helicase And Its
Interactions With Primase
pdb|3BGW|B Chain B, The Structure Of A Dnab-like Replicative Helicase And Its
Interactions With Primase
pdb|3BGW|C Chain C, The Structure Of A Dnab-like Replicative Helicase And Its
Interactions With Primase
pdb|3BGW|D Chain D, The Structure Of A Dnab-like Replicative Helicase And Its
Interactions With Primase
pdb|3BGW|E Chain E, The Structure Of A Dnab-like Replicative Helicase And Its
Interactions With Primase
pdb|3BGW|F Chain F, The Structure Of A Dnab-like Replicative Helicase And Its
Interactions With Primase
Length = 444
Score = 26.9 bits (58), Expect = 2.6, Method: Composition-based stats.
Identities = 15/33 (45%), Positives = 19/33 (57%), Gaps = 5/33 (15%)
Query: 36 IYRNDYYKKEGEGLLPVSFAITVVIESKNRSVP 68
+YR+DYY KE E S I VI +K+R P
Sbjct: 392 LYRDDYYDKESE-----SKNIVEVIIAKHRDGP 419
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 26.9 bits (58), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 13/30 (43%), Positives = 18/30 (60%), Gaps = 4/30 (13%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLA 33
+HRD+ + N + + VKIGDFGLA
Sbjct: 154 IHRDMKSNNIFLH----EGLTVKIGDFGLA 179
>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
pdb|2R0I|B Chain B, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
Length = 327
Score = 26.9 bits (58), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 16/33 (48%), Positives = 18/33 (54%), Gaps = 4/33 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
VHRDL A N L LD I KI DFG + +
Sbjct: 135 VHRDLKAENLL---LDADMNI-KIADFGFSNEF 163
>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
pdb|1ZMU|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
Length = 327
Score = 26.9 bits (58), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 16/33 (48%), Positives = 18/33 (54%), Gaps = 4/33 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
VHRDL A N L LD I KI DFG + +
Sbjct: 135 VHRDLKAENLL---LDADMNI-KIADFGFSNEF 163
>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
pdb|2QNJ|B Chain B, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
Length = 328
Score = 26.9 bits (58), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 16/32 (50%), Positives = 18/32 (56%), Gaps = 4/32 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARD 35
VHRDL A N L LD I KI DFG + +
Sbjct: 133 VHRDLKAENLL---LDADMNI-KIADFGFSNE 160
>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|B Chain B, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|C Chain C, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|D Chain D, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
Length = 319
Score = 26.9 bits (58), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 16/33 (48%), Positives = 18/33 (54%), Gaps = 4/33 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
VHRDL A N L LD I KI DFG + +
Sbjct: 128 VHRDLKAENLL---LDADMNI-KIADFGFSNEF 156
>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|B Chain B, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|C Chain C, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|D Chain D, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|E Chain E, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|F Chain F, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
Length = 327
Score = 26.9 bits (58), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 16/33 (48%), Positives = 18/33 (54%), Gaps = 4/33 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
VHRDL A N L LD I KI DFG + +
Sbjct: 135 VHRDLKAENLL---LDADMNI-KIADFGFSNEF 163
>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
pdb|1ZMV|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
Length = 327
Score = 26.9 bits (58), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 16/33 (48%), Positives = 18/33 (54%), Gaps = 4/33 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
VHRDL A N L LD I KI DFG + +
Sbjct: 135 VHRDLKAENLL---LDADMNI-KIADFGFSNEF 163
>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
pdb|1ZMW|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
Length = 327
Score = 26.9 bits (58), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 16/33 (48%), Positives = 18/33 (54%), Gaps = 4/33 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
VHRDL A N L LD I KI DFG + +
Sbjct: 135 VHRDLKAENLL---LDADMNI-KIADFGFSNEF 163
>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
pdb|3FE3|B Chain B, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
Length = 328
Score = 26.9 bits (58), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 16/32 (50%), Positives = 18/32 (56%), Gaps = 4/32 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARD 35
VHRDL A N L LD I KI DFG + +
Sbjct: 136 VHRDLKAENLL---LDADMNI-KIADFGFSNE 163
>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|C Chain C, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|D Chain D, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|E Chain E, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|F Chain F, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|G Chain G, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|H Chain H, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
Length = 328
Score = 26.9 bits (58), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 16/34 (47%), Positives = 19/34 (55%), Gaps = 4/34 (11%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARD 35
+ VHRDL A N L LD I KI DFG + +
Sbjct: 134 YIVHRDLKAENLL---LDGDMNI-KIADFGFSNE 163
>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
pdb|1Y8G|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
Length = 327
Score = 26.9 bits (58), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 16/33 (48%), Positives = 18/33 (54%), Gaps = 4/33 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
VHRDL A N L LD I KI DFG + +
Sbjct: 135 VHRDLKAENLL---LDADXNI-KIADFGFSNEF 163
>pdb|3OJC|A Chain A, Crystal Structure Of A Putative AspGLU RACEMASE FROM
YERSINIA PESTIS
pdb|3OJC|B Chain B, Crystal Structure Of A Putative AspGLU RACEMASE FROM
YERSINIA PESTIS
pdb|3OJC|C Chain C, Crystal Structure Of A Putative AspGLU RACEMASE FROM
YERSINIA PESTIS
pdb|3OJC|D Chain D, Crystal Structure Of A Putative AspGLU RACEMASE FROM
YERSINIA PESTIS
Length = 231
Score = 26.9 bits (58), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 14/51 (27%), Positives = 26/51 (50%), Gaps = 3/51 (5%)
Query: 33 ARDIYRNDYYKKEGEGLLPVSFA---ITVVIESKNRSVPFRPELCVYGPLA 80
+RD YR K E +G+ + F IT+++ +++ SVP ++ A
Sbjct: 175 SRDAYRRVIKKLEAQGVQGIIFGCTEITLLVNAQDASVPVFDTTAIHASAA 225
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 26.9 bits (58), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 13/30 (43%), Positives = 19/30 (63%), Gaps = 3/30 (10%)
Query: 5 HRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
HRD+ +N L LDP ++K+ DFG A+
Sbjct: 164 HRDIKPQNLL---LDPPSGVLKLIDFGSAK 190
>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain.
pdb|3DB8|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 041
pdb|3DBC|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 257
pdb|3DBD|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 094
Length = 317
Score = 26.6 bits (57), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 18/43 (41%), Positives = 24/43 (55%), Gaps = 6/43 (13%)
Query: 4 VHRDLAARNCLVSC-LDPKYRIVKIGDFGLARDIYRNDYYKKE 45
+HRDL N ++ +D VKIGDFGLA I + KK+
Sbjct: 164 IHRDLKLGNLFLNDDMD-----VKIGDFGLATKIEFDGERKKD 201
>pdb|4GMJ|A Chain A, Structure Of Human Not1 Mif4g Domain Co-Crystallized With
Caf1
pdb|4GMJ|C Chain C, Structure Of Human Not1 Mif4g Domain Co-Crystallized With
Caf1
pdb|4GMJ|E Chain E, Structure Of Human Not1 Mif4g Domain Co-Crystallized With
Caf1
Length = 229
Score = 26.6 bits (57), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 21/66 (31%), Positives = 32/66 (48%), Gaps = 8/66 (12%)
Query: 41 YYKKEGEGLLPVSFAITVVIESKNRSVPFRP----ELCVYGPLADIDSIKKVGIN---KI 93
Y K + E L V F + V+ES RSV FRP + + LA++ + +N +I
Sbjct: 137 YVKGQQELLYVVPF-VAKVLESSIRSVVFRPPNPWTMAIMNVLAELHQEHDLKLNLKFEI 195
Query: 94 GTICPN 99
+C N
Sbjct: 196 EVLCKN 201
>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 902
pdb|3D5X|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Wortmannin.
pdb|3DBE|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 557
pdb|3DBF|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 562
Length = 301
Score = 26.6 bits (57), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 18/43 (41%), Positives = 24/43 (55%), Gaps = 6/43 (13%)
Query: 4 VHRDLAARNCLVSC-LDPKYRIVKIGDFGLARDIYRNDYYKKE 45
+HRDL N ++ +D VKIGDFGLA I + KK+
Sbjct: 148 IHRDLKLGNLFLNDDMD-----VKIGDFGLATKIEFDGERKKD 185
>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|2OWB|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|3FC2|A Chain A, Plk1 In Complex With Bi6727
Length = 335
Score = 26.6 bits (57), Expect = 4.0, Method: Compositional matrix adjust.
Identities = 16/41 (39%), Positives = 22/41 (53%), Gaps = 4/41 (9%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKK 44
+HRDL N ++ + VKIGDFGLA + + KK
Sbjct: 163 IHRDLKLGNLFLN----EDLEVKIGDFGLATKVEYDGERKK 199
>pdb|4GML|A Chain A, Crystal Structure Of Human Not1 Mif4g Domain
pdb|4GML|B Chain B, Crystal Structure Of Human Not1 Mif4g Domain
pdb|4GML|C Chain C, Crystal Structure Of Human Not1 Mif4g Domain
pdb|4GML|D Chain D, Crystal Structure Of Human Not1 Mif4g Domain
pdb|4GML|E Chain E, Crystal Structure Of Human Not1 Mif4g Domain
pdb|4GML|F Chain F, Crystal Structure Of Human Not1 Mif4g Domain
Length = 235
Score = 26.6 bits (57), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 21/66 (31%), Positives = 32/66 (48%), Gaps = 8/66 (12%)
Query: 41 YYKKEGEGLLPVSFAITVVIESKNRSVPFRP----ELCVYGPLADIDSIKKVGIN---KI 93
Y K + E L V F + V+ES RSV FRP + + LA++ + +N +I
Sbjct: 143 YVKGQQELLYVVPF-VAKVLESSIRSVVFRPPNPWTMAIMNVLAELHQEHDLKLNLKFEI 201
Query: 94 GTICPN 99
+C N
Sbjct: 202 EVLCKN 207
>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 311
Score = 26.6 bits (57), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 16/41 (39%), Positives = 22/41 (53%), Gaps = 4/41 (9%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKK 44
+HRDL N ++ + VKIGDFGLA + + KK
Sbjct: 139 IHRDLKLGNLFLN----EDLEVKIGDFGLATKVEYDGERKK 175
>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
pdb|2V5Q|B Chain B, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
Length = 315
Score = 26.6 bits (57), Expect = 4.2, Method: Compositional matrix adjust.
Identities = 16/41 (39%), Positives = 22/41 (53%), Gaps = 4/41 (9%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKK 44
+HRDL N ++ + VKIGDFGLA + + KK
Sbjct: 143 IHRDLKLGNLFLN----EDLEVKIGDFGLATKVEYDGERKK 179
>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With
Nms-P937
pdb|4A4L|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
5-(2-Amino-Pyrimidin-4-Yl)-1h-Pyrrole Inhibitor
pdb|4A4O|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
2-
(2-Amino-Pyrimidin-4-Yl)-1,5,6,
7-Tetrahydro-Pyrrolopyridin- 4-One Inhibitor
Length = 311
Score = 26.2 bits (56), Expect = 4.3, Method: Compositional matrix adjust.
Identities = 16/41 (39%), Positives = 22/41 (53%), Gaps = 4/41 (9%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKK 44
+HRDL N ++ + VKIGDFGLA + + KK
Sbjct: 139 IHRDLKLGNLFLN----EDLEVKIGDFGLATKVEYDGERKK 175
>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A
Benzolactam-Derived Inhibitor
Length = 333
Score = 26.2 bits (56), Expect = 4.3, Method: Compositional matrix adjust.
Identities = 16/41 (39%), Positives = 22/41 (53%), Gaps = 4/41 (9%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKK 44
+HRDL N ++ + VKIGDFGLA + + KK
Sbjct: 161 IHRDLKLGNLFLN----EDLEVKIGDFGLATKVEYDGERKK 197
>pdb|4G36|A Chain A, Photinus Pyralis Luciferase In The Adenylate-Forming
Conformation Bound To Dlsa
pdb|4G36|B Chain B, Photinus Pyralis Luciferase In The Adenylate-Forming
Conformation Bound To Dlsa
Length = 555
Score = 26.2 bits (56), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 17/60 (28%), Positives = 29/60 (48%), Gaps = 11/60 (18%)
Query: 44 KEGEGLLPVSFAITVVIESKNRS------VPFRPELCVYGPLADIDSIKKVGINKIGTIC 97
++G GL + AI + E ++ VPF V D+D+ K +G+N+ G +C
Sbjct: 342 RQGYGLTETTSAILITPEGDDKPGAVGKVVPFFEAKVV-----DLDTGKTLGVNQRGELC 396
>pdb|1BA3|A Chain A, Firefly Luciferase In Complex With Bromoform
pdb|1LCI|A Chain A, Firefly Luciferase
pdb|3RIX|A Chain A, 1.7a Resolution Structure Of A Firefly
Luciferase-Aspulvinone J Inhibitor Complex
pdb|4E5D|A Chain A, 2.2a Resolution Structure Of A Firefly
Luciferase-Benzothiazole Inhibitor Complex
Length = 550
Score = 26.2 bits (56), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 17/60 (28%), Positives = 29/60 (48%), Gaps = 11/60 (18%)
Query: 44 KEGEGLLPVSFAITVVIESKNRS------VPFRPELCVYGPLADIDSIKKVGINKIGTIC 97
++G GL + AI + E ++ VPF V D+D+ K +G+N+ G +C
Sbjct: 337 RQGYGLTETTSAILITPEGDDKPGAVGKVVPFFEAKVV-----DLDTGKTLGVNQRGELC 391
>pdb|3IEP|A Chain A, Firefly Luciferase Apo Structure (P41 Form)
pdb|3IER|A Chain A, Firefly Luciferase Apo Structure (P41 Form) With Peg 400
Bound
pdb|3IES|A Chain A, Firefly Luciferase Inhibitor Complex
Length = 551
Score = 26.2 bits (56), Expect = 4.7, Method: Compositional matrix adjust.
Identities = 17/60 (28%), Positives = 29/60 (48%), Gaps = 11/60 (18%)
Query: 44 KEGEGLLPVSFAITVVIESKNRS------VPFRPELCVYGPLADIDSIKKVGINKIGTIC 97
++G GL + AI + E ++ VPF V D+D+ K +G+N+ G +C
Sbjct: 337 RQGYGLTETTSAILITPEGDDKPGAVGKVVPFFEAKVV-----DLDTGKTLGVNQRGELC 391
>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536
Length = 294
Score = 26.2 bits (56), Expect = 4.7, Method: Compositional matrix adjust.
Identities = 16/41 (39%), Positives = 22/41 (53%), Gaps = 4/41 (9%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKK 44
+HRDL N ++ + VKIGDFGLA + + KK
Sbjct: 137 IHRDLKLGNLFLN----EDLEVKIGDFGLATKVEYDGERKK 173
>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1)
Catalytic Domain
Length = 317
Score = 26.2 bits (56), Expect = 4.9, Method: Compositional matrix adjust.
Identities = 18/42 (42%), Positives = 23/42 (54%), Gaps = 6/42 (14%)
Query: 4 VHRDLAARNCLVSC-LDPKYRIVKIGDFGLARDIYRNDYYKK 44
+HRDL N ++ +D VKIGDFGLA I + KK
Sbjct: 164 IHRDLKLGNLFLNDDMD-----VKIGDFGLATKIEFDGERKK 200
>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1
(Plk1) Catalytic Domain In Complex With Adp
Length = 317
Score = 26.2 bits (56), Expect = 4.9, Method: Compositional matrix adjust.
Identities = 18/42 (42%), Positives = 23/42 (54%), Gaps = 6/42 (14%)
Query: 4 VHRDLAARNCLVSC-LDPKYRIVKIGDFGLARDIYRNDYYKK 44
+HRDL N ++ +D VKIGDFGLA I + KK
Sbjct: 164 IHRDLKLGNLFLNDDMD-----VKIGDFGLATKIEFDGERKK 200
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 25.8 bits (55), Expect = 6.9, Method: Compositional matrix adjust.
Identities = 18/48 (37%), Positives = 26/48 (54%), Gaps = 5/48 (10%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLL 50
++RDL N + +D K VKIGDFGL + +ND + +G L
Sbjct: 143 LINRDLKPSNIFL--VDTKQ--VKIGDFGLVTSL-KNDGKRXRSKGTL 185
>pdb|3BH0|A Chain A, Atpase Domain Of G40p
Length = 315
Score = 25.4 bits (54), Expect = 8.3, Method: Compositional matrix adjust.
Identities = 15/33 (45%), Positives = 19/33 (57%), Gaps = 5/33 (15%)
Query: 36 IYRNDYYKKEGEGLLPVSFAITVVIESKNRSVP 68
+YR+DYY KE E S I VI +K+R P
Sbjct: 263 LYRDDYYDKESE-----SKNIVEVIIAKHRDGP 290
>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native
pdb|3MFS|A Chain A, Cask-4m Cam Kinase Domain, Amppnp
pdb|3MFT|A Chain A, Cask-4m Cam Kinase Domain, Mn2+
pdb|3MFU|A Chain A, Cask-4m Cam Kinase Domain, Amppnp-Mn2+
Length = 351
Score = 25.0 bits (53), Expect = 9.9, Method: Compositional matrix adjust.
Identities = 12/30 (40%), Positives = 19/30 (63%), Gaps = 1/30 (3%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLA 33
+HRD+ N L++ + VK+GDFG+A
Sbjct: 152 IHRDVKPENVLLASKE-NSAPVKLGDFGVA 180
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.326 0.145 0.452
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 3,481,486
Number of Sequences: 62578
Number of extensions: 132697
Number of successful extensions: 1065
Number of sequences better than 100.0: 485
Number of HSP's better than 100.0 without gapping: 263
Number of HSP's successfully gapped in prelim test: 222
Number of HSP's that attempted gapping in prelim test: 506
Number of HSP's gapped (non-prelim): 509
length of query: 113
length of database: 14,973,337
effective HSP length: 77
effective length of query: 36
effective length of database: 10,154,831
effective search space: 365573916
effective search space used: 365573916
T: 11
A: 40
X1: 15 ( 7.1 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 40 (21.6 bits)
S2: 45 (21.9 bits)